isTab: false

2017

Transplantation in Germany
Nashan B, Hugo C, Strassburg C, Arbogast H, Rahmel A, Lilie H
TRANSPLANTATION. 2017;101(2):213-218.

A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis
Neumann K, Karimi K, Meiners J, Voetlause R, Steinmann S, Dammermann W, Lüth S, Asghari F, Wegscheid C, Horst A, Tiegs G
J IMMUNOL. 2017;198(1):128-137.

High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection
von Felden J, Heim D, Schulze K, Krech T, Ewald F, Nashan B, Lohse A, Wege H
BMC CANCER. 2017;17(1):60.

2016

High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System success or waste of organs? The Eurotransplant 15-year all-centre survey
Assfalg V, Hüser N, van Meel M, Haller B, Rahmel A, de Boer J, Matevossian E, Novotny A, Knops N, Weekers L, Friess H, Pratschke J, Függer R, Janko O, Rasoul-Rockenschaub S, Bosmans J, Broeders N, Peeters P, Mourad M, Kuypers D, Slaviček J, Muehlfeld A, Sommer F, Viebahn R, Pascher A, van der Giet M, Zantvoort F, Woitas R, Putz J, Grabitz K, Kribben A, Hauser I, Pisarski P, Weimer R, Lorf T, Fornara P, Morath C, Nashan B, Lehner F, Kliem V, Sester U, Grimm M, Feldkamp T, Kleinert R, Arns W, Mönch C, Schoenberg M, Nitschke M, Krüger B, Thorban S, Arbogast H, Wolters H, Maier T, Lutz J, Heller K, Banas B, Hakenberg O, Kalus M, Nadalin S, Keller F, Lopau K, Bemelman F, Nurmohamed S, Sanders J, de Fijter J, Christiaans M, Hilbrands L, Betjes M, van Zuilen A, Heemann U
NEPHROL DIAL TRANSPL. 2016;31(9):1515-22.

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation
Ciesek S, Proske V, Otto B, Pischke S, Costa R, Lütgehetmann M, Polywka S, Klempnauer J, Nashan B, Manns M, von Hahn T, Lohse A, Wedemeyer H, Mix H, Sterneck M
TRANSPL INFECT DIS. 2016;18(3):326-32.

Do patient characteristics influence efficacy and renal outcomes in liver transplant patients receiving everolimus?
De Simone P, Saliba F, Dong G, Escrig C, Fischer L
CLIN TRANSPLANT. 2016;30(3):279-88.

Variations and adaptations of associated liver partition and portal vein ligation for staged hepatectomy (ALPPS): Many routes to the summit
Edmondson M, Sodergren M, Pucher P, Darzi A, Li J, Petrowsky H, Campos R, Serrablo A, Jiao L
SURGERY. 2016;159(4):1058-72.

Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4
Grottke A, Ewald F, Lange T, Nörz D, Herzberger C, Bach J, Grabinski N, Gräser L, Höppner F, Nashan B, Schumacher U, Jücker M
PLOS ONE. 2016;11(1):e0146370.

Early Initiation of Everolimus After Liver Transplantation: A Single-Center Experience
Herden U, Galante A, Fischer L, Pischke S, Li J, Achilles E, Koch M, Nashan B, Sterneck M
ANN TRANSPLANT. 2016;21:77-85.

Selection and use of immunosuppressive therapies after liver transplantation current German practice
Herzer K, Strassburg C, Braun F, Engelmann C, Guba M, Lehner F, Nadalin S, Pascher A, Scherer M, Schnitzbauer A, Zimmermann T, Nashan B, Sterneck M
CLIN TRANSPLANT. 2016;30(5):487-501.

Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis - a retrospective multicenter analysis
Hildebrand T, Pannicke N, Dechene A, Gotthardt D, Kirchner G, Reiter F, Sterneck M, Herzer K, Lenzen H, Rupp C, Barg-Hock H, de Leuw P, Teufel A, Zimmer V, Lammert F, Sarrazin C, Spengler U, Rust C, Manns M, Strassburg C, Schramm C, Weismüller T
LIVER TRANSPLANT. 2016;22(1):42-52.

Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection
Koch M, Poehnert D, Nashan B
TRANSPL IMMUNOL. 2016;35:12-7.

Avoid "All-Touch" by Hybrid ALPPS to Achieve Oncological Efficacy
Li J, Kantas A, Ittrich H, Koops A, Achilles E, Fischer L, Nashan B
ANN SURG. 2016;263(1):E6-E7.

Associating liver partition and portal vein ligation for staged hepatectomy:From technical evolution to oncological benefit
Li J, Ewald F, Gulati A, Nashan B
World J Gastrointest Surg. 2016;8(2):124-133.

Prediction, prevention, and management of delayed graft function where are we now?
Nashan B, Abbud-Filho M, Citterio F
CLIN TRANSPLANT. 2016;30(10):1198-1208.

Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting
Pischke S, Polywka S, Proske V, Lang M, Jordan S, Nashan B, Lohse A, Sterneck M
TRANSPL INFECT DIS. 2016;18:141-145.

Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy
Radtke J, Dietze N, Fischer L, Achilles E, Li J, Scheidat S, Thaiss F, Nashan B, Koch M
TRANSPL INFECT DIS. 2016;18(6):850-855.

Surgical complications after peritoneal dialysis catheter implantation depend on children's weight
Radtke J, Lemke A, Kemper M, Nashan B, Koch M
J PEDIATR SURG. 2016;51(8):1317-20.

Fewer cytomegalovirus complications after kidney transplantation by de novo use of mTOR inhibitors in comparison to mycophenolic acid
Radtke J, Dietze N, Spetzler V, Fischer L, Achilles E, Li J, Scheidat S, Thaiss F, Nashan B, Koch M
TRANSPL INFECT DIS. 2016;18(1):79-88.

Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death
Saran S, Tran D, Ewald F, Koch A, Hoffmann A, Koch M, Nashan B, Tamura T
ONCOGENE. 2016;35(29):3872-9.

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
Shen Z, Liu Y, Dewidar B, Hu J, Park O, Feng T, Xu C, Yu C, Li Q, Meyer C, Ilkavets I, Müller A, Stump-Guthier C, Munker S, Liebe R, Zimmer V, Lammert F, Mertens P, Li H, Ten Dijke P, Augustin H, Li J, Gao B, Ebert M, Dooley S, Li Y, Weng H
AM J PATHOL. 2016;186(7):1874-89.

Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients,study protocol for a randomised controlled trial
Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser I, Nashan B, Thaiss F
TRIALS. 2016;17:92.

14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation
Thude H, Janssen M, Sterneck M, Nashan B, Koch M
HUM IMMUNOL. 2016;77(12):1159-1165.

Extracellular-signal regulated kinase (Erk1/2), mitogen-activated protein kinase-activated protein kinase 2 (MK2) and tristetraprolin (TTP) comprehensively regulate injury-induced immediate early gene (IEG) response in in vitro liver organ culture
Tran D, Koch A, Saran S, Armbrecht M, Ewald F, Koch M, Wahlicht T, Wirth D, Braun A, Nashan B, Gaestel M, Tamura T
CELL SIGNAL. 2016;28(5):438-47.

Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP)
Tran D, Koch A, Allister A, Saran S, Ewald F, Koch M, Nashan B, Tamura T
CELL SIGNAL. 2016;28(12):1872-1880.

The influence of PEEP and positioning on central venous pressure and venous hepatic hemodynamics in patients undergoing liver resection
Ukere A, Meisner S, Greiwe G, Opitz B, Benten D, Nashan B, Fischer L, Trepte C, Reuter D, Haas S, Behem C
J CLIN MONIT COMPUT. 2016 [Epub ahead of print].

Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach Transplantation
Zimmermann T, Beckebaum S, Berg C, Berg T, Braun F, Eurich D, Herzer K, Neumann U, Rupp C, Sterneck M, Strassburg C, Welker M, Zachoval R, Gotthardt D, Weigand K, Schmidt H, Wedemeyer H, Galle P, Zeuzem S, Sarrazin C
Z GASTROENTEROL. 2016;54(7):665-84.

2015

Determination of ethyl glucuronide in hair for detection of alcohol consumption in patients after livertransplantation.
Andresen-Streichert H, von Rothkirch G, Vettorazzi E, Müller A, Lohse A, Frederking D, Seegers B, Nashan B, Sterneck M
THER DRUG MONIT. 2015;37(4):539-545.

Successful detoxification and liver transplantation in a severe poisoning with a chemical wood preservative containing chromium, copper, and arsenic
Breuer C, Oh J, Nolkemper D, Achilles E, Fischer L, Eglite I, Güsmer C, Heitland P, Koester H, Brinkert F, Singer D, Blohm M
TRANSPLANTATION. 2015;99(4):e29-30.

Association between a gain-of-function variant of PTPN22 and rejection in liver transplantation
Dullin R, Koch M, Sterneck M, Nashan B, Thude H
TRANSPLANTATION. 2015;99(2):431-7.

Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
Ewald F, Nörz D, Grottke A, Bach J, Herzberger C, Hofmann B, Nashan B, Jücker M
J CANCER. 2015;6(12):1195-205.

Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study
Fischer L, Saliba F, Kaiser G, De Carlis L, Metselaar H, De Simone P, Duvoux C, Nevens F, Fung J, Dong G, Rauer B, Junge G
TRANSPLANTATION. 2015;99(7):1455-62.

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting
Galante A, Pischke S, Polywka S, Lütgehetmann M, Suneetha P, Gisa A, Hiller J, Dienes H, Nashan B, Lohse A, Sterneck M
TRANSPL INFECT DIS. 2015;17(4):617-22.

Long-Term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation
Grabhorn E, Binder T, Obrecht D, Brinkert F, Lehnhardt A, Herden U, Peine S, Nashan B, Ganschow R, Briem-Richter A
TRANSPLANTATION. 2015;99(9):1876-1881.

Aktueller Stand der immunsuppressiven Therapie unter Berücksichtigung des transplantierten Patienten in der Chirurgie
Herden U, Nashan B, Koch M
Allgemein- und Viszeralchirurgie up2date. 2015;9(03):232-245.

Is There a Role for Liver Transplantation in Non-Colorectal Liver Metastases?
Herden U, Nashan B
Viszeralmedizin. 2015;31(6):400-4.

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
Hofmann B, Schlüter L, Lange P, Mercanoglu B, Ewald F, Fölster A, Picksak A, Harder S, El Gammal A, Grupp K, Güngör C, Drenckhan A, Schlüter H, Wagener C, Izbicki J, Jücker M, Bockhorn M, Wolters-Eisfeld G
MOL CANCER. 2015;14(1):109.

Everolimus and sirolimus in transplantation-related but different
Klawitter J, Nashan B, Christians U
EXPERT OPIN DRUG SAF. 2015;14(7):1055-1070.

Extracellular Vesicles from MSC Modulate the Immune Response to Renal Allografts in a MHC Disparate Rat Model
Koch M, Lemke A, Lange C
Stem Cells Int. 2015;2015:486141.

Surgical complications after kidney transplantation: different impacts of immunosuppression, graft function, patient variables, and surgical performance
Koch M, Kantas A, Ramcke K, Drabik A, Nashan B
CLIN TRANSPLANT. 2015;29(3):252-60.

De novo mTOR inhibitor based immunosuppression in ABO incompatible kidney transplantation
Koch M, Wiech T, Marget M, Peine S, Thude H, Achilles E, Fischer L, Lehnhardt A, Thaiss F, Nashan B
CLIN TRANSPLANT. 2015.

Anterior vertical mini-incision versus retroperitoneoscopic nephrectomy in living kidney donation: A prospective study on donors' quality of life and clinical outcome
Kroencke S, Schulz K, Nashan B, Koch M
CLIN TRANSPLANT. 2015;29(11):1029-1038.

High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction
Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, Koch M
CLIN TRANSPLANT. 2015.

Rat renal transplant model for mixed acute humoral and cellular rejection: Weak correlation of serum cytokines/chemokines with intragraft changes
Lemke A, Noriega M, Röske A, Kemper M, Nashan B, Falk C, Koch M
TRANSPL IMMUNOL. 2015;33(2):95-102.

Definition of Chronic Hepatitis E after Liver Transplantation Conforms to Convention
Meisner S, Polywka S, Memmler M, Nashan B, Lohse A, Sterneck M, Pischke S
AM J TRANSPLANT. 2015;15(11):3011-3012.

Regarding "Compared Efficacy of Preservation Solutions in Liver Transplantation A Long-Term Graft Outcome Study From the European Liver Transplant Registry"
Nashan B, Spetzler V, Schemmer P, Kirste G, Rahmel A
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2015;15(12):3272-3.

Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
Nashan B, Schemmer P, Braun F, Dworak M, Wimmer P, Schlitt H
TRIALS. 2015;16(1):118.

Discontinuing MEK inhibitors in tumor cells with an acquired resistance increases migration and invasion
Nörz D, Grottke A, Bach J, Herzberger C, Hofmann B, Nashan B, Jücker M, Ewald F
CELL SIGNAL. 2015;27(11):2191-200.

Monosegment ALPPS hepatectomy: extending resectability by rapid hypertrophy
Schadde E, Malagó M, Hernandez-Alejandro R, Li J, Abdalla E, Ardiles V, Lurje G, Vyas S, Machado M, de Santibañes E
SURGERY. 2015;157(4):676-89.

Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen L, Klümpen H, Lohse A, Nashan B, Primrose J, Schrum S, Shannon J, Vettorazzi E, Wege H
BMC CANCER. 2015;15:Art. 564.

A German survey of the abdominal transplantation surgical work force
Thomas M, Nadalin S, Schemmer P, Pascher A, Kaiser G, Braun F, Becker T, Nashan B, Guba M
TRANSPL INT. 2015;28(7):849-56.

Role of the Fyn -93A>G polymorphism (rs706895) in acute rejection after liver transplantation
Thude H, Kramer K, Peine S, Sterneck M, Nashan B, Koch M
HUM IMMUNOL. 2015;76(9):657-662.

2014

Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue
David K, Unger F, Uhlig P, Juhl H, Moore H, Compton C, Nashan B, Dörner A, de Weerth A, Zornig C
ONCOTARGET. 2014;5(22):11017-28.

Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors
Ewald F, Nörz D, Grottke A, Hofmann B, Nashan B, Jücker M
INVEST NEW DRUG. 2014;32(6):1144-54.

Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: a single-center experience and a review of the literature
Grabhorn E, Tsiakas K, Herden U, Fischer L, Freisinger P, Marquardt T, Ganschow R, Briem-Richter A, Santer R
LIVER TRANSPLANT. 2014;20(4):464-72.

Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells
Grabinski N, Ewald F
INVEST NEW DRUG. 2014;32(6):1096-1104.

Outcome of liver re-transplantation in children-Impact and special analysis of early re-transplantation
Herden U, Ganschow R, Grabhorn E, Briem-Richter A, Nashan B, Fischer L
PEDIATR TRANSPLANT. 2014;18(4):377-84.

Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant
Herden U, Grabhorn E, Briem-Richter A, Ganschow R, Nashan B, Fischer L
CLIN TRANSPLANT. 2014;28(9):1061-8.

ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer
Hofmann B, Stehr A, Dohrmann T, Güngör C, Herich L, Hiller J, Harder S, Ewald F, Gebauer F, Tachezy M, Precht C, Izbicki J, Bockhorn M, Wagener C, Wolters-Eisfeld G
CLIN CANCER RES. 2014;20(23):6117-26.

Family strain and its relation to psychosocial dysfunction in children and adolescents after liver transplantation
Kaller T, Petersen I, Petermann F, Fischer L, Grabhorn E, Schulz K
PEDIATR TRANSPLANT. 2014;18(8):851-9.

Liver Remnant Regeneration in Donors After Living Donor Liver Transplantation: Long-Term Follow-Up Using CT and MR Imaging
Klink T, Simon P, Knopp T, Ittrich H, Fischer L, Adam G, Koops A
ROFO-FORTSCHR RONTG. 2014;186(6):598-605.

Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study
Klintmalm G, Feng S, Lake J, Vargas H, Wekerle T, Agnes S, Brown K, Nashan B, Rostaing L, Meadows-Shropshire S, Agarwal M, Harler M, Garcia-Valdecasas J
AM J TRANSPLANT. 2014;14(8):1817-27.

The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
Klintmalm G, Nashan B
J Transplant. 2014;2014:845438.

The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy
Klintmalm G, Saab S, Hong J, Nashan B
CLIN TRANSPLANT. 2014;28(6):635-48.

Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients
Kramer K, Thye T, Treszl A, Peine S, Koch M, Sterneck M, Nashan B, Thude H
TISSUE ANTIGENS. 2014;84(4):370-7.

Donor quality of life up to two years after living donor liver transplantation: a prospective study
Kroencke S, Nashan B, Fischer L, Erim Y, Schulz K
TRANSPLANTATION. 2014;97(5):582-589.

Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons Learned from 15 cases at a single centre
Nadalin S, Capobianco I, Li J, Girotti P, Königsrainer I, Königsrainer A
Z GASTROENTEROL. 2014;52(1):35-42.

mTOR inhibitors and their role in modern concepts of immunosuppression
Nashan B
WORLD J SURG. 2014;38(12):3199-201.

Improvement in gastrointestinal and health-related quality of life outcomes after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant recipients
Sterneck M, Settmacher U, Ganten T, Sarrazin C, Speidel N, Broering D, Heyne N, Paulus E, Mertens M, Fischer L
TRANSPL P. 2014;46(1):234-240.

Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation
Sterneck M, Kaiser G, Heyne N, Richter N, Rauchfuss F, Pascher A, Schemmer P, Fischer L, Klein C, Nadalin S, Lehner F, Settmacher U, Neuhaus P, Gotthardt D, Loss M, Ladenburger S, Paulus E, Mertens M, Schlitt H
AM J TRANSPLANT. 2014;14(3):701-10.

Determination of ethyl glucuronide in hair for detection of alcohol consumption in patients after liver transplantation
Sterneck M, von Rothkirch G, Andresen-Streichert H, Vettorazzi E, Schulze K, Nashan B
2014.

Lack of association between CD40 polymorphisms and acute rejection in German liver transplant recipients
Thude H, Kramer K, Koch M, Peine S, Sterneck M, Nashan B
HUM IMMUNOL. 2014;75(11):1123-7.

The diagnosis and treatment of cholangiocarcinoma
Vogel A, Wege H, Caca K, Nashan B, Neumann U
DTSCH ARZTEBL INT. 2014;111(44):748-54.

2013

Treatment of liver transplant graft-versus-host disease with antibodies against tumor necrosis factor-α
Blank G, Li J, Kratt T, Handgretinger R, Königsrainer A, Nadalin S
CLIN TRANSPLANT. 2013;11(1):68-71.

Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.
Brennan D, Aguado J, Potena L, Jardine A, Legendre C, Säemann M, Mueller N, Merville P, Emery V, Nashan B
REV MED VIROL. 2013;23(2):97-125.

Peripheral blood biomarkers for the characterization of alloimmune reactivity after pediatric liver transplantation
Briem-Richter A, Leuschner A, Krieger T, Grabhorn E, Fischer L, Nashan B, Haag F, Ganschow R
PEDIATR TRANSPLANT. 2013;17(8):757-64.

Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome.
Brinkert F, Lehnhardt A, Montoya C, Helmke K, Schäfer H, Fischer L, Nashan B, Bergmann C, Ganschow R, Kemper M
TRANSPL INT. 2013;26(6):640-650.

Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials
Cooper M, Wiseman A, Zibari G, McCague K, Kim Y, Geissler F, Nashan B
CLIN TRANSPLANT. 2013;27(6):E625-35.

Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
Ewald F, Grabinski N, Grottke A, Windhorst S, Nörz D, Carstensen L, Staufer K, Hofmann B, Diehl F, David K, Schumacher U, Nashan B, Jücker M
INT J CANCER. 2013;133(9):2065-76.

Successful outcome of severe Amanita phalloides poisoning in children
Grabhorn E, Nielsen D, Hillebrand G, Brinkert F, Herden U, Fischer L, Ganschow R
PEDIATR TRANSPLANT. 2013;17(6):550-5.

A formula to calculate the standard liver volume in children and its application in pediatric liver transplantation
Herden U, Wischhusen F, Heinemann A, Ganschow R, Grabhorn E, Vettorazzi E, Nashan B, Fischer L
TRANSPL INT. 2013;26(12):1217-24.

Transcapsular arterial neovascularization of liver transplants increases the risk of intraoperative bleeding during retransplantation.
Herrmann J, Herden U, Ganschow R, Petersen K, Schmid F, Derlin T, Koops A, Peine S, Sterneck M, Fischer L, Helmke K
TRANSPL INT. 2013;26(4):419-427.

Cognitive performance in pediatric liver transplant recipients
Kaller T, Langguth N, Petermann F, Ganschow R, Nashan B, Schulz K
AM J TRANSPLANT. 2013;13(11):2956-65.

Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival
Koch M, Lehnhardt A, Hu X, Brunswig-Spickenheier B, Stolk M, Bröcker V, Noriega M, Seifert M, Lange C
TRANSPL IMMUNOL. 2013;29(1-4):43-50.

Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib.
Koch M, Graeser C, Lehnhardt A, Pollok J, Kröger N, Verboom M, Thaiss F, Eiermann T, Nashan B
TRANSPL INT. 2013;26(8):64-68.

Comparing Surgical Complications of Donors and Recipients in Retroperitoneoscopic versus Mini-Incision Donor Nephrectomy: A Single-Center Experience
Koch M, Bachmann A, Nashan B
ISRN Transplantation. 2013;5.

Supportive care needs in patients with cardiovascular disorders.
Kohlmann S, Kilbert M, Ziegler K, Schulz K
PATIENT EDUC COUNS. 2013;91(3):378-384.

ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure?
Li J, Girotti P, Königsrainer I, Ladurner R, Königsrainer A, Nadalin S
J GASTROINTEST SURG. 2013;17(5):956-961.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Liu J, Hov J, Folseraas T, Ellinghaus E, Rushbrook S, Doncheva N, Andreassen O, Weersma R, Weismüller T, Eksteen B, Invernizzi P, Hirschfield G, Gotthardt D, Pares A, Ellinghaus D, Shah T, Juran B, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen M, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen C, Croucher P, Sterneck M, Teufel A, Mason A, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich S, Thompson W, Schork A, Næss S, Thomsen I, Mayr G, König I, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford R, Durie P, Melum E, Vatn M, Silverberg M, Duerr R, Padyukov L, Brand S, Sans M, Annese V, Achkar J, Boberg K, Marschall H, Chazouillères O, Bowlus C, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M, Rioux J, Alexander G, Bergquist A, Cho J, Schreiber S, Manns M, Färkkilä M, Dale A, Chapman R, Lazaridis K, Franke A, Anderson C, Karlsen T
NAT GENET. 2013;45(6):670-5.

Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection
Logge C, Vettorazzi E, Fischer L, Nashan B, Sterneck M
TRANSPL INT. 2013;26(5):527-34.

Reperfusion of liver graft during Transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature
Manzini G, Kremer M, Houben P, Gondan M, Bechstein W, Becker T, Berlakovich G, Friess H, Guba M, Hohenberger W, Ijzermans J, Jonas S, Kalff J, Klar E, Klempnauer J, Lerut J, Lippert H, Lorf T, Nadalin S, Nashan B, Otto G, Paul A, Pirenne J, Pratschke J, Ringers J, Rogiers X, Schilling M, Seehofer D, Senninger N, Settmacher U, Stippel D, Tscheliessnigg K, Ysebaert D, Binder H, Schemmer P
TRANSPL INT. 2013;26(5):508-16.

Induction therapy and mTOR Inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients
Nashan B
CLIN TRANSPLANT. 2013;27 Suppl 25:16-29.

Extended pancreas donor program - the EXPAND study rationale and study protocol
Proneth A, Schnitzbauer A, Zeman F, Foerster J, Holub I, Arbogast H, Bechstein W, Becker T, Dietz C, Guba M, Heise M, Jonas S, Kersting S, Klempnauer J, Manekeller S, Müller V, Nadalin S, Nashan B, Pascher A, Rauchfuss F, Ströhlein M, Schemmer P, Schenker P, Thorban S, Vogel T, Rahmel A, Viebahn R, Banas B, Geissler E, Schlitt H, Farkas S
Transplant Res. 2013;2(1):12.

Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Raghu G, Million-Rousseau R, Morganti A, Perchenet L, Behr J, , Nashan B
EUR RESPIR J. 2013;42(6):1622-32.

Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma
Schulze K, Gasch C, Staufer K, Nashan B, Lohse A, Pantel K, Riethdorf S, Wege H
INT J CANCER. 2013;133(9):2165-71.

Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates
Sterneck M, Yegles M, von Rothkirch G, Staufer K, Vettorazzi E, Schulz K, Tobias N, Graeser C, Fischer L, Nashan B, Andresen-Streichert H
LIVER INT. 2013.

Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients
Thude H, Schipler A, Treszl A, Peine S, Koch M, Sterneck M, Nashan B
HUM IMMUNOL. 2013;74(8):1041-5.

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Volz T, Allweiss L, Ben MBarek M, Warlich M, Lohse A, Pollok J, Alexandrov A, Urban S, Petersen J, Lütgehetmann M, Dandri M
J HEPATOL. 2013;58(5):861-7.

2012

Primary human hepatocytes from metabolic-disordered children recreate highly differentiated liver-tissue-like spheroids on alginate scaffolds.
Bierwolf J, Lütgehetmann M, Deichmann S, Erbes J, Volz T, Dandri-Petersen M, Cohen S, Nashan B, Pollok J
TISSUE ENG. 2012;18(13-14):1443-1453.

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT.
Fischer L, Klempnauer J, Beckebaum S, Metselaar H, Neuhaus P, Schemmer P, Settmacher U, Heyne N, Clavien P, Muehlbacher F, Morard I, Wolters H, Vogel W, Becker T, Sterneck M, Lehner F, Klein C, Kazemier G, Pascher A, Schmidt J, Rauchfuss F, Schnitzbauer A, Nadalin S, Hack M, Ladenburger S, Schlitt H
AM J TRANSPLANT. 2012;12(7):1855-1865.

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
Folseraas T, Melum E, Rausch P, Juran B, Ellinghaus E, Shiryaev A, Laerdahl J, Ellinghaus D, Schramm C, Weismüller T, Gotthardt D, Hov J, Clausen O, Weersma R, Janse M, Boberg K, Björnsson E, Marschall H, Cleynen I, Rosenstiel P, Holm K, Teufel A, Rust C, Gieger C, Wichmann H, Bergquist A, Ryu E, Ponsioen C, Runz H, Sterneck M, Vermeire S, Beuers U, Wijmenga C, Schrumpf E, Manns M, Lazaridis K, Schreiber S, Baines J, Franke A, Karlsen T
J HEPATOL. 2012;57(2):366-375.

Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.
Gareau A, Nashan B, Hirsch G, Lee T
J HEART LUNG TRANSPL. 2012;31(8):874-880.

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
Grabinski N, Ewald F, Hofmann B, Staufer K, Schumacher U, Nashan B, Jücker M
MOL CANCER. 2012;11:85.

A prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.
Kasiske B, Nashan B, Maria D, Raffaele P, Russ G, Campistol J, Pescovitz M, Keown P
J Transplant. 2012;2012:107180.

A prospective study on living related kidney donors' quality of life in the first year: choosing appropriate reference data.
Kröncke S, Fischer L, Nashan B, Herich L, Schulz K
CLIN TRANSPLANT. 2012;26(4):418-427.

Morbidity rate of reoperation in thyroid surgery: a different point of view.
Kurmann A, Herden U, Schmid S, Candinas D, Seiler C
SWISS MED WKLY. 2012;142:13643.

Elevated serum levels of B-cell activating factor in pediatric renal transplant patients.
Lehnhardt A, Dunst F, Van Husen M, Loos S, Oh J, Eiermann T, Koch M, Kemper M
PEDIATR NEPHROL. 2012;27(8):1389-1395.

Timing and risk factors of hepatectomy in the management of complications following laparoscopic cholecystectomy.
Li J, Frilling A, Nadalin S, Broelsch C, Malago M
J GASTROINTEST SURG. 2012;16(4):815-820.

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M, Mancke L, Volz T, Helbig M, Allweiss L, Bornscheuer T, Pollok J, Lohse A, Petersen J, Urban S, Dandri-Petersen M
HEPATOLOGY. 2012;55(3):685-694.

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients.
Nashan B, Gaston R, Emery V, Säemann M, Mueller N, Couzi L, Dantal J, Shihab F, Mulgaonkar S, Yu S, Brennan D
TRANSPLANTATION. 2012;93(11):1075-1085.

Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature.
Nashan B, Citterio F
TRANSPLANTATION. 2012;94(6):547-561.

Heparin-induced thrombocytopenia associated with acute liver graft failure.
Pannicke N, Pollok J, Kluge S, Petzoldt M
BMJ Case Rep. 2012;2012:7323.

Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.
Petersen J, Ratziu V, Buti M, Janssen H, Brown A, Lampertico P, Schollmeyer J, Zoulim F, Wedemeyer H, Sterneck M, Berg T, Sarrazin C, Lütgehetmann M, Buggisch P
J HEPATOL. 2012;56(3):520-526.

Milzverletzung im Rahmen einer Koloskopie mit tödlichem Verlauf. Ärztliches Fehlverhalten?
Schrot M, Peters A, Denzer U, Karbe T, Schulz F
RECHTSMEDIZIN. 2012;22:126-129.

[Long-term outcome with end-stage renal disease - survival is not enough: does dialysis or kidney transplantation matter?].
Schulz K, Thaiss F
BUNDESGESUNDHEITSBLATT. 2012;55(4):543-551.

High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation.
Staufer K, Fischer L, Seegers B, Vettorazzi E, Nashan B, Sterneck M
TRANSPL INT. 2012;25(11):1158-1164.

The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.
Suwelack B, Malyar V, Koch M, Sester M, Sommerer C
Transplant Rev (Orlando). 2012;26(3):201-211.

No association between transmembrane protein-tyrosine phosphatase receptor type C (PTPRC) exon A 77C>G transversion and liver transplant rejection.
Thude H, Schipler A, Treszl A, Sterneck M, Nashan B
INT J IMMUNOGENET. 2012;39(5):437-441.

Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Volz T, Lütgehetmann M, Allweiss L, Warlich M, Bierwolf J, Pollok J, Petersen J, Matthes E, Dandri-Petersen M
ANTIVIR THER. 2012;17(4):623-631.

In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor
Vondran F, Eiermann T, Thaiss F, Schwinzer R, Nashan B, Koch M
TRANSPLANTATION. 2012;93(6):e23-5.

Fatigue-Syndrom nach Nieren-Lebendspende? Studienlage ergibt keinen Anhalt für signifikante Beeinträchtigung der Lebensqualität im Vergleich zur Normalbevölkerung
Weidemann A, Kröncke S, Schulz K, Nashan B, Banas B, Eckardt K
Nephro-news. 2012;14(1/2):19-21.

2011

Expression of CD133 and other putative stem cell markers in uveal melanoma.
Berna-Thill M, Berna M, Grierson R, Reinhart I, Voelkel T, Piechaczek C, Galambos P, Jager M, Richard G, Lange C, Gehling U
MELANOMA RES. 2011;21(5):405-416.

Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical research.
Bierwolf J, Lütgehetmann M, Feng K, Erbes J, Deichmann S, Toronyi E, Stieglitz C, Nashan B, Ma P, Pollok J
BIOTECHNOL BIOENG. 2011;108(1):141-150.

High prevalence of renal dysfunction in children after liver transplantation: non-invasive diagnosis using a cystatin C-based equation.
Brinkert F, Kemper M, Briem-Richter A, Van Husen M, Treszl A, Ganschow R
NEPHROL DIAL TRANSPL. 2011;26(4):1407-1412.

Everolimus and long-term outcomes in renal transplantation.
Campistol J, Fijter d, Nashan B, Nashan B, Holdaas H, Vítko S, Legendre C
TRANSPLANTATION. 2011;92(3 Suppl):3-26.

Liver regeneration associated protein (ALR) exhibits anti-metastatic potential in hepatocellular carcinoma.
Dayoub R, Wagner H, Bataille F, Stöltzing O, Spruss T, Buechler C, Schlitt H, Weiss T
MOL MED. 2011;17(3-4):221-228.

Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial.
Fischer L, Trunečka P, Gridelli B, Roy A, Vitale A, Valdivieso A, Varo E, Seehofer D, Lynch S, Samuel D, Ericzon B, Boudjema K, Karpf C, Undre N
LIVER TRANSPLANT. 2011;17(2):167-177.

Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
Friman S, Arns W, Nashan B, Vincenti F, Banas B, Budde K, Cibrik D, Chan L, Klempnauer J, Mulgaonkar S, Nicholson M, Wahlberg J, Wissing K, Abrams K, Witte S, Woodle E
AM J TRANSPLANT. 2011;11(7):1444-1455.

Pediatrics: Liver transplantation in very small recipients.
Ganschow R
NAT CLIN PRACT GASTR. 2011;8(11):606-607.

Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies.
Goralczyk A, Hauke N, Bari N, Tsui T, Lorf T, Obed A
HEPATOLOGY. 2011;54(2):541-554.

Liver transplantation in patients with liver cirrhosis and active pneumonia: an observational study.
Goralczyk A, Abu-Ajaj W, Tsui T, Bauer M, Lorf T, Ramadori G, Obed A
TRANSPL INT. 2011;24(11):1068-1074.

Posterior cavoplasty: a new approach to avoid venous outflow obstruction and symptoms for small-for-size syndrome in right lobe living donor liver transplantation.
Goralczyk A, Obed A, Beham A, Tsui T, Lorf T
LANGENBECK ARCH SURG. 2011;396(3):389-395.

Lebensmüde ernten ihr Gift neuerdings im Wald ... Suizidversuch mit Knollenblätterpilz
Harlandt O, Wichmann D, de Heer G, Fischer L, Nashan B, Reimer J, Benten D, Lohse A, Kluge S
Medical Tribune. 2011;43(40):7.

Der besondere Fall · Suizidversuch mit Knollenblätterpilz
Harlandt O, Wichmann D, de Heer G, Fischer L, Nashan B, Reimer J, Benten D, Lohse A, Kluge S
Hamb Arztebl. 2011;65(5):34-35.

Immediate postoperative intensive care treatment of pediatric combined liver-kidney transplantation: outcome and prognostic factors.
Harps E, Brinkert F, Ganschow R, Briem-Richter A, Van Husen M, Schmidtke S, Herden U, Nashan B, Fischer L, Kemper M
TRANSPLANTATION. 2011;91(10):1127-1131.

Intrathyroid adenomas in primary hyperparathyroidism: are they frequent enough to guide surgical strategy?
Herden U, Seiler C, Candinas D, Schmid S
SURG INNOV. 2011;18(4):373-378.

Surgical aspects and outcome of combined liver and kidney transplantation in children.
Herden U, Kemper M, Ganschow R, Klaassen I, Grabhorn E, Brinkert F, Nashan B, Fischer L
TRANSPL INT. 2011;24(8):805-811.

Monitoring of nuclear factor of activated T-cell-regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine a.
Herden U, Kromminga A, Hagel C, Hartleb J, Nashan B, Sterneck M, Fischer L
THER DRUG MONIT. 2011;33(2):185-191.

Liver transplantation in children using organs from young paediatric donors.
Herden U, Ganschow R, Briem-Richter A, Helmke K, Nashan B, Fischer L
TRANSPL INT. 2011;24(6):610-618.

Transcapsular arterial neovascularization after liver transplantation in pediatric patients indicates transplant failure.
Herrmann J, Junge C, Burdelski M, Ganschow R, Scheibner S, Petersen K, Fischer L, Broering D, Adam G, Helmke K
RADIOLOGY. 2011;261(2):566-572.

Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
Hofer H, Aydin I, Neumueller-Guber S, Mueller C, Scherzer T, Staufer K, Steindl-Munda P, Wrba F, Ferenci P
J VIRAL HEPATITIS. 2011.

Parvovirus B19 infection and autoimmune hepatitis in a child with sickle cell anemia.
Kordes U, Schneppenheim R, Briem-Richter A, Scherpe S, Schäfer H
PEDIATR BLOOD CANCER. 2011;56(2):323-324.

Radiation rescue: mesenchymal stromal cells protect from lethal irradiation.
Lange C, Brunswig-Spickenheier B, Capallo-Obermann H, Eggert K, Gehling U, Rudolph C, Schlegelberger B, Cornils K, Zustin J, Spiess A, Zander A
PLOS ONE. 2011;6(1):14486.

Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.
Lütgehetmann M, Bornscheuer T, Volz T, Allweiss L, Bockmann J, Pollok J, Lohse A, Petersen J, Dandri-Petersen M
GASTROENTEROLOGY. 2011;140(7):1-2, 2074-2083.

The use of everolimus in pediatric liver transplant recipients: first experience in a single center.
Nielsen D, Briem-Richter A, Sornsakrin M, Fischer L, Nashan B, Ganschow R
PEDIATR TRANSPLANT. 2011;15(5):510-514.

RGB marking facilitates multicolor clonal cell tracking.
Riecken K, Thomaschewski M, Warlich M, Volz T, Cornils K, Niebuhr B, Täger M, Lütgehetmann M, Pollok J, Stocking C, Dandri-Petersen M, Benten D, Fehse B
NAT MED. 2011;17(4):504-509.

[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].
Schlitt H, Loss M, Scherer M, Becker T, Jauch K, Nashan B, Schmidt H, Settmacher U, Rogiers X, Neuhaus P, Strassburg C
Z GASTROENTEROL. 2011;49(1):30-38.

To donate or not to donate: decision making and psychosocial determinants in living liver donation.
Schulz K, Kröncke S
TRANSPLANTATION. 2011;92(8):846-847.

Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysis.
Settmacher U, Götz M, Rahmel A, Bärthel E, Schlitt H, Puhl G, Broering D, Lehner F, Fischer L, Paul A, Schmidt J, Nadalin S, Obed A, Heise M
TRANSPL INT. 2011;24(9):904-911.

Drug abuse, personality disorder, and colorectal metastases: when chemotherapy becomes an illusion and surgery cannot help any more.
Sotiropoulos G, Tagkalos E, Molmenti E, Gönner U, Stöltzing O, Mildenberger P, Lang H
INT J COLORECTAL DIS. 2011;26(2):261-262.

Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption.
Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M
HEPATOLOGY. 2011;54(5):1640-1649.

Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineering.
Török-Pollok E, Lütgehetmann M, Bierwolf J, Melbeck S, Düllmann J, Nashan B, Ma P, Pollok J
LIVER TRANSPLANT. 2011;17(2):104-114.

Prospective evaluation of biliary reconstruction with duct-to-duct continuous suture in adult live donor liver transplantation.
Tsui T, Schlitt H, Obed A
LANGENBECK ARCH SURG. 2011;396(2):209-215.

Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin.
Walter J, Sobottka I, Rogiers X, Broering D, Fischer L
MYCOSES. 2011;54(4):220-222.

Pregnancy in primary sclerosing cholangitis.
Wellge B, Sterneck M, Teufel A, Rust C, Franke A, Schreiber S, Berg T, Günther R, Kreisel W, Zu Eulenburg C, Braun F, Beuers U, Galle P, Lohse A, Schramm C
GUT. 2011;60(8):1117-1121.

2010

[Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].
Arnold D, Stöltzing O, Timm S, Stein A, Geissler M, Lang H
Z GASTROENTEROL. 2010;48(12):1375-1383.

Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation.
Boillot O, Seehofer D, Pinna A, Fischer L, Fischer L, Troisi R, Baccarani U, Ortiz de Urbina J, Wall W, Group T
AM J TRANSPLANT. 2010;10(10):2313-2323.

Hemorrhagic necrotizing pancreatitis with a huge pseudocyst in a child with Crohn's disease.
Briem-Richter A, Grabhorn E, Wenke K, Ganschow R
EUR J GASTROEN HEPAT. 2010;22(2):234-236.

Rescue allocation offers in liver transplantation: is there any reason to reject unwanted organs?
Doenecke A, Scherer M, Tsui T, Schnitzbauer A, Schlitt H, Obed A
SCAND J GASTROENTERO. 2010;45(12):1516-1517.

Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation.
Esch J, Jurk K, Knoefel W, Roeder G, Voss H, Tustas R, Schmelzle M, Krieg A, Eisenberger C, Topp S, Rogiers X, Fischer L, Aken H, Kehrel B
PLATELETS. 2010;21(5):348-359.

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
Frilling A, Sotiropoulos G, Radtke A, Malago M, Bockisch A, Kuehl H, Li J, Broelsch C
ANN SURG. 2010;252(5):850-856.

Zu selten diagnostiziert: Autoimmunhepatitis
Ganschow R
Arztl Prax Padiatrie. 2010;4:30-32.

Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis.
Gehling U, Willems M, Schlagner K, Benndorf R, Dandri-Petersen M, Petersen J, Sterneck M, Pollok J, Hossfeld D, Rogiers X
WORLD J GASTROENTERO. 2010;16(2):217-224.

Responsiveness of patient-based and external rating scales in multiple sclerosis: head-to-head comparison in three clinical settings.
Gold S, Schulz H, Stein H, Solf K, Schulz K, Heesen C
J NEUROL SCI. 2010;290(1-2):102-106.

A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT.
Goralczyk A, Schnitzbauer A, Tsui T, Ramadori G, Lorf T, Obed A
BMC SURG. 2010;10:15.

Glucose-6-phosphate dehydrogenase deficiency: a contraindication for living donor liver transplantation?
Goralczyk A, Moser C, Scherer M, Tsui T, Doenecke A, Lorf T, Schlitt H, Obed A
TRANSPL INT. 2010;23(11):65-66.

Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models.
Hackl C, Mori A, Moser C, Lang S, Dayoub R, Weiss T, Schlitt H, Geissler E, Hellerbrand C, Stöltzing O
SURGERY. 2010;147(5):704-712.

Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.
Hackl C, Lang S, Moser C, Mori A, Fichtner-Feigl S, Hellerbrand C, Dietmeier W, Schlitt H, Geissler E, Stöltzing O
BMC CANCER. 2010;10:668.

Correlates of cognitive dysfunction in multiple sclerosis.
Heesen C, Schulz K, Fiehler J, Von der Mark U, Otte C, Jung R, Poettgen J, Krieger T, Gold S
BRAIN BEHAV IMMUN. 2010;24(7):1148-1155.

Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient.
Herden U, Fischer L, Schäfer H, Nashan B, von Baehr V, Sterneck M
TRANSPLANTATION. 2010;90(1):98-99.

Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.
Hofer H, Donnerer J, Sator K, Staufer K, Scherzer T, Dejaco C, Sator M, Kessler H, Ferenci P
J HEPATOL. 2010;52(6):812-816.

ADP-dependent platelet function prior to and in the early course of pediatric liver transplantation and persisting thrombocytopenia are positively correlated with ischemia/reperfusion injury.
Jan S, Akyildiz A, Tustas R, Ganschow R, Schmelzle M, Krieg A, Robson S, Topp S, Rogiers X, Knoefel W, Fischer L
TRANSPL INT. 2010;23(7):745-752.

Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.
Kirchner G, Kirovski G, Hebestreit A, Schölmerich J, Schlitt H, Stöltzing O, Hellerbrand C
Int J Clin Exp Med. 2010;3(2):169-179.

Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells.
Lang S, Hackl C, Moser C, Fichtner-Feigl S, Koehl G, Schlitt H, Geissler E, Stöltzing O
BBA-MOL CELL RES. 2010;1803(4):435-442.

Surgical management of segmental and sectoral bile duct injury after laparoscopic cholecystectomy: a challenging situation.
Li J, Frilling A, Nadalin S, Radunz S, Treckmann J, Lang H, Malago M, Broelsch C
J GASTROINTEST SURG. 2010;14(2):344-351.

Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma.
Müller S, Poehnert D, Müller J, Scheumann G, Koch M, Lück R
WORLD J SURG. 2010;34(7):1481-1487.

Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment.
Schnitzbauer A, Doenecke A, Sothmann J, Loss M, Farkas S, Hartl J, Tsui T, Baier L, Kirchner G, Obed A, Bein T, Geissler E, Scherer M, Schlitt H
EUR SURG RES. 2010;45(3-4):356-367.

Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry.
Schramm C, Bubenheim M, Adam R, Karam V, Buckels J, O'Grady J, Jamieson N, Pollard S, Neuhaus P, Manns M, Porte R, Castaing D, Paul A, Traynor O, Garden J, Friman S, Ericzon B, Fischer L, Vitko S, Krawczyk M, Metselaar H, Foss A, Kilic M, Rolles K, Burra P, Rogiers X, Lohse A
LIVER TRANSPLANT. 2010;16(4):461-469.

Regeneration of corneal endothelium following complete endothelial cell loss in rat keratoplasty.
Schwartzkopff J, Bredow L, Mahlenbrey S, Boehringer D, Reinhard T
MOL VIS. 2010;16:2368-2375.

Die Lebertransplantation im Kindesalter: Aktuelle Entwicklungen
Sornsakrin M, Briem-Richter A, Nashan B, Ganschow R
Kinder Jugendmed. 2010;10(6):343-346.

Das erweiterte Führungszeugnis: Eine Hilfestellung für die Prävention von sexuellem Missbrauch
Spehr A, Ganschow R
Z SEXUALFORSCH. 2010;23(3):277-282.

Implication of heat shock protein 90 (HSP90) in tumor angiogenesis: a molecular target for anti-angiogenic therapy?
Staufer K, Stöltzing O
CURR CANCER DRUG TAR. 2010;10(8):890-897.

Sirolimus addition to tacrolimus-based immunosuppression induces complete remission of post-transplant lymphoproliferative disorder in a liver transplant recipient.
Staufer K, Sterneck M, Schäfer H, Nashan B, Fischer L
TRANSPL INT. 2010;23(10):1068-1070.

Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor.
Stöltzing O, Loss M, Huber E, Gross V, Eilles C, Mueller-Brand J, Schlitt H
LANGENBECK ARCH SURG. 2010;395(2):185-192.

Dual-targeting of mTOR and HSP90 for cancer therapy: Facing oncogenic feed-back-loops and acquired mTOR resistance.
Stöltzing O
CELL CYCLE. 2010;9(11):2051-2052.

No association between transmembrane protein-tyrosine-phosphatase receptor type C (CD45) exon A 77C>G transversion and Hashimoto's thyroiditis in a German population.
Thude H, Weissenborn S, Vilser C, Müller U, Kloos C, Wolf G, Beck J, Barz D
HUM IMMUNOL. 2010;71(2):220-223.

Identification of the novel allele Cw*040110 in a German patient.
Thude H, Michael M, Loth M, Schorner U, Barz D
TISSUE ANTIGENS. 2010;75(1):80-82.

Five-year safety and efficacy of belatacept in renal transplantation.
Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran P, Klempnauer J, Lang P, Larsen C, Mühlbacher F, Nashan B, Soulillou J, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, Shi R, Townsend R, Charpentier B
J AM SOC NEPHROL. 2010;21(9):1587-1596.

2009

Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.
Benten D, Staufer K, Sterneck M
NAT CLIN PRACT GASTR. 2009;6(1):23-36.

Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth.
Brinkert F, Ganschow R, Helmke K, Harps E, Fischer L, Nashan B, Hoppe B, Kulke S, Müller-Wiefel D, Kemper M
TRANSPLANTATION. 2009;87(9):1415-1421.

Prevalence of polyomavirus viruria (JC virus/BK virus) in children following liver transplantation.
Brinkert F, Briem-Richter A, Ilchmann C, Kemper M, Ganschow R
PEDIATR TRANSPLANT. 2009.

Low N-acetyltransferase 2 activity in isoniazid-associated acute hepatitis requiring liver transplantation.
Cramer J, Lohse A, Burchard G, Fischer L, Nashan B, Zimmermann M, Marx A, Kluge S
TRANSPL INT. 2009.

Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity.
Doenecke A, Tsui T, Zuelke C, Scherer M, Schnitzbauer A, Schlitt H, Obed A
CLIN TRANSPLANT. 2009.

Contribution of B cells and antibody to cardiac allograft vasculopathy.
Gareau A, Hirsch G, Lee T, Nashan B
TRANSPLANTATION. 2009;88(4):470-477.

Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience.
Goralczyk A, Obed A, Schnitzbauer A, Doenecke A, Tsui T, Scherer M, Ramadori G, Lorf T
J Transplant. 2009;2009:759581.

Everolimus in liver and lung transplantation.
Koch M
DRUG TODAY. 2009;45(1):11-20.

Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
Koch M, Becker T, Lueck R, Neipp M, Klempnauer J, Nashan B
Biologics. 2009;3:51-56.

Basiliximab induction therapy in kidney transplantation
Koch M, Becker T, Lueck R, Neipp M, Klempnauer J, Nashan B
Biologics. 2009;3:51-6.

The value of immunoprophylaxis for cytomegalovirus infection with intravenous immunoglobulin in pediatric liver transplant recipients receiving a low-dose immunosupressive regimen.
Krampe K, Briem-Richter A, Fischer L, Nashan B, Ganschow R
PEDIATR TRANSPLANT. 2009.

Mycophenolic Acid exposure after administration of mycophenolate mofetil in the presence and absence of ciclosporin in renal transplant recipients.
Kuypers D, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok R, Bouw R
CLIN PHARMACOKINET. 2009;48(5):329-341.

A cell penetrating heme oxygenase protein protects heart graft against ischemia/reperfusion injury.
Ma J, Lau C, Obed A, Dada A, Doenecke A, Fan S, Schlitt H, Tsui T
GENE THER. 2009;16(3):320-328.

Long-term survival after surgery for primary hepatic sarcoma in adults.
Matthaei H, Krieg A, Schmelzle M, Boelke E, Poremba C, Rogiers X, Knoefel W, Peiper M
ARCH SURG-CHICAGO. 2009;144(4):339-344.

Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando). 2009;23(1):47-52.

Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
Nashan B, Saliba F, Durand F, Barcéna R, Herrero J, Mentha G, Neuhaus P, Bowles M, Patch D, Bernardos A, Klempnauer J, Bouw R, Ives J, Mamelok R, McKay D, Truman M, Marotta P
LIVER TRANSPLANT. 2009;15(2):136-147.

Prospective observational study of sirolimus as primary immunosuppression after renal transplantation.
Pescovitz M, Nezakatgoo N, Lorber M, Nashan B, Tedesco-Silva H, Kasiske B, Cruz d, Juarez F, Russ G, Campistol J, Keown P
TRANSPLANTATION. 2009;88(8):1010-1018.

Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility.
Poehnert D, Broecker V, Mengel M, Nashan B, Koch M
TRANSPL IMMUNOL. 2009.

Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?
Sancho-Bru P, Najimi M, Caruso M, Pauwelyn K, Cantz T, Forbes S, Roskams T, Ott M, Gehling U, Sokal E, Verfaillie C, Muraca M
GUT. 2009;58(4):594-603.

Is right laparoscopic donor nephrectomy right?
Sawatzky M, Altaf A, Ellsmere J, Klassen D, Walsh M, Molinari M, Nashan B, Bonjer J
SURG ENDOSC. 2009;23(6):1321-1325.

Liver transplantation for sclerosing cholangitis in a polytraumatized patient.
Schnitzbauer A, Tsui T, Kirchner G, Scherer M, Bein T, Schlitt H, Obed A
NAT CLIN PRACT GASTR. 2009;6(2):121-126.

Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options.
Schrader J, Sterneck M, Klose H, Lohse A, Nashan B, Fischer L
TRANSPL INT. 2009.

Mental and physical quality of life in actual living liver donors versus potential living liver donors: a prospective, controlled, multicenter study.
Schulz K, Kröncke S, Beckmann M, Nadalin S, Paul A, Fischer L, Nashan B, Senf W, Erim Y
LIVER TRANSPLANT. 2009;15(12):1676-1687.

Adult living donor liver transplantation: body mass index and MELD score of recipients are independent risk factors for hospital mortality.
Tsui T, Scherer M, Schnitzbauer A, Schlitt H, Obed A
LANGENBECK ARCH SURG. 2009;394(2):235-241.

2008

Low recurrence of preexisting extrahepatic malignancies after liver transplantation.
Benten D, Sterneck M, Panse J, Rogiers X, Lohse A
LIVER TRANSPLANT. 2008;14(6):789-798.

Analysis of the CC chemokine receptor 5Delta32 polymorphism in pediatric liver transplant recipients.
Fischer-Maas L, Schneppenheim R, Oyen F, Grabhorn E, Briem-Richter A, Fischer L, Ganschow R
PEDIATR TRANSPLANT. 2008;12(7):769-772.

Neonates with severe infantile hepatic hemangioendothelioma: limitations of liver transplantation.
Grabhorn E, Briem-Richter A, Fischer L, Krebs-Schmitt D, Ganschow R
PEDIATR TRANSPLANT. 2008.

Emergency liver transplantation in neonates with acute liver failure: long-term follow-up.
Grabhorn E, Briem-Richter A, Fischer L, Ganschow R
TRANSPLANTATION. 2008;86(7):932-936.

Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases.
Grannas G, Neipp M, Hoeper M, Gottlieb J, Lück R, Becker T, Simon A, Strassburg C, Manns M, Welte T, Haverich A, Klempnauer J, Nashan B, Strueber M
TRANSPLANTATION. 2008;85(4):524-531.

Association of four DNA polymorphisms with acute rejection after kidney transplantation.
Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L
TRANSPL INT. 2008;21(9):879-891.

Bladder tamponade due to vesical varices during orthotopic liver transplantation.
Herden U, Seiler C, Candinas D, Schmid S
TRANSPL INT. 2008;21(11):1105-1106.

Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
Koch M, Broecker V, Heratizadeh A, Doege C, Strehlau J, Mengel M, Nashan B
TRANSPL IMMUNOL. 2008;19(3-4):187-191.

Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.
Kovarik J, Villamil F, Otero A, Levy G, Lynch S, Cillo U, Fischer L, Nashan B, Pollard S, Luciano D
CLIN TRANSPLANT. 2008;22(1):68-75.

Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor?
Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering D
ANN SURG ONCOL. 2008;15(7):1908-1917.

Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
Obed A, Tsui T, Schnitzbauer A, Obed M, Schlitt H, Becker H, Lorf T
LANGENBECK ARCH SURG. 2008;393(2):141-147.

Living donor liver resection: a low-tech but highly efficient technique. The Regensburg experience.
Obed A, Schnitzbauer A, Tsui T, Gosh H, Jarrad A, Bashir A, Schlitt H
LANGENBECK ARCH SURG. 2008;393(3):413-421.

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J, Dandri-Petersen M, Mier W, Lütgehetmann M, Volz T, von Weizsäcker F, Haberkorn U, Fischer L, Pollok J, Erbes B, Seitz S, Urban S
NAT BIOTECHNOL. 2008;26(3):335-341.

Contrast harmonic ultrasound and indocyanine-green fluorescence video angiography for evaluation of dermal and subdermal microcirculation in free parascapular flaps.
Prantl L, Schmitt S, Gais S, Tsui T, Lamby P, Babilas P, Nerlich M, Kubale R, Zorger N, Herold T, Feuerbach S, Jung E
CLIN HEMORHEOL MICRO. 2008;38(1):31-44.

Liver transplantation for fulminant hepatic failure in infancy: A single center experience.
Strauss A, Grabhorn E, Sornsakrin M, Briem-Richter A, Fischer L, Nashan B, Ganschow R
PEDIATR TRANSPLANT. 2008.

Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C, Kuhlencordt R, Grotelüschen R, Wedegärtner U, Ang T, Adam G, Soehendra N, Seitz U
ENDOSCOPY. 2008;40(9):739-745.

CD8+ gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen.
Zhou J, Appleton S, Stadnyk A, Lee T, Nashan B
TRANSPL INT. 2008;21(7):679-687.

2007

Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension.
Benndorf R, Gehling U, Appel D, Maas R, Schwedhelm E, Schlagner K, Silberhorn E, Hossfeld D, Rogiers X, Böger R
STEM CELLS DEV. 2007;16(2):329-338.

A novel population of repair cells identified in the stroma of the human cornea.
Berna-Thill M, Schlagner K, Altenähr S, Ergün S, Faragher R, Kilic N, Bednarz J, Vohwinkel G, Rogiers X, Hossfeld D, Richard G, Gehling U
STEM CELLS DEV. 2007;16(5):733-745.

The type of arterial anastomosis influences hepatic hemodynamics and overall survival in liver graft recipients.
Boozari B, Nashan B, Hecker H, Kubicka S, Klempnauer J, Strassburg C, Manns M, Gebel M
ULTRASCHALL MED. 2007;28(6):587-592.

Small intestine transplantation today.
Braun F, Bröring D, Faendrich F
LANGENBECK ARCH SURG. 2007;392(3):227-238.

Clinical relevance of autoantibodies after pediatric liver transplantation.
Briem-Richter A, Grabhorn E, Helmke K, Manns M, Ganschow R, Burdelski M
CLIN TRANSPLANT. 2007;21(3):427-432.

The first two cases of living donor liver transplantation using dual grafts in Europe.
Bröring D, Walter J, Rogiers X
LIVER TRANSPLANT. 2007;13(1):149-153.

Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve.
Chalajour F, Treede H, Gehling U, Ebrahimnejad A, Boehm D, Riemer R, Ergun S, Reichenspurner H
EXP CELL RES. 2007;313(11):2326-2335.

Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy.
Chapman J, Valantine H, Albanell J, Arns W, Campistol J, Eisen H, Frigerio M, Lehmkuhl H, Marcen R, Morris R, Nashan B, Pascual J, Pohanka E, Segovia J, Zuckermann A
TRANSPL P. 2007;39(10):2937-2950.

The choice of recipient does not have a bearing on early outcome in liver transplant patients receiving grafts from non-heart-beating donors: a reappraisal?
Dezza M, Berrevoet F, Sainz-Barriga M, Rossetto A, Colenbie L, Haentjens I, Van Vlierberghe H, Colle I, Van Huysse J, Praet M, Rogiers X, de Hemptinne B, Troisi R
TRANSPL P. 2007;39(8):2675-2677.

Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.
Ekberg H, Grinyó J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M
AM J TRANSPLANT. 2007;7(3):560-570.

Reduced exposure to calcineurin inhibitors in renal transplantation.
Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó J, Frei U, Vanrenterghem Y, Daloze P, Halloran P
NEW ENGL J MED. 2007;357(25):2562-2575.

Liver transplantation in children with progressive familial intrahepatic cholestasis.
Englert C, Grabhorn E, Briem-Richter A, Rogiers X, Burdelski M, Ganschow R
TRANSPLANTATION. 2007;84(10):1361-1363.

Non-bone-marrow-derived endothelial progenitor cells: what is their exact location?
Ergün S, Gehling U
CIRC RES. 2007;101(3):31.

Potential implications of vascular wall resident endothelial progenitor cells.
Ergün S, Tilki D, Hohn H, Gehling U, Kilic N
THROMB HAEMOSTASIS. 2007;98(5):930-939.

Psychological strain in urgent indications for living donor liver transplantation.
Erim Y, Beckmann M, Kröncke S, Valentin-Gamazo C, Malago M, Bröring D, Rogiers X, Frilling A, Broelsch C, Schulz K
LIVER TRANSPLANT. 2007;13(6):886-895.

Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients.
Foote C, Greer W, Kiberd B, Fraser A, Lawen J, Nashan B, Belitsky P
TRANSPLANTATION. 2007;83(10):1380-1384.

CFU-EC: how they were originally defined.
Gehling U, Ergün S, Fiedler W
BLOOD. 2007;110(3):1073.

Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients.
Koch M, Mengel M, Poehnert D, Nashan B
TRANSPLANTATION. 2007;83(4):498-505.

Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.
Laryea M, Watt K, Molinari M, Walsh M, McAlister V, Marotta P, Nashan B, Peltekian K
LIVER TRANSPLANT. 2007;13(8):1109-1114.

Imatinib mesylate inhibits proliferation and modulates cytokine expression of human cancer-associated stromal fibroblasts from colorectal metastases.
Mueller L, Goumas F, Himpel S, Brilloff S, Rogiers X, Bröring D
CANCER LETT. 2007;250(2):329-338.

Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment.
Mueller L, Goumas F, Affeldt M, Sandtner S, Gehling U, Brilloff S, Walter J, Karnatz N, Lamszus K, Rogiers X, Bröring D
AM J PATHOL. 2007;171(5):1608-1618.

[Skin tumors in organ-transplant recipients]
Nashan D, Radny P, Kösters N, Nashan B
HAUTARZT. 2007;58(1):48-50, 52-53.

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients: pooled results from three international, multicenter studies.
Pietruck F, Abbud-Filho M, Vathsala A, Massari P, Po-Huang L, Nashan B
TRANSPL P. 2007;39(1):103-108.

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
Rosenau J, Kreutz T, Kujawa M, Bahr M, Rifai K, Hooman N, Finger A, Michel G, Nashan B, Kuse E, Klempnauer J, Tillmann H, Manns M
J HEPATOL. 2007;46(4):635-644.

Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease.
Rudolph V, Steven D, Gehling U, Goldmann B, Rudolph T, Friedrichs K, Meinertz T, Heitzer T, Baldus S
FREE RADICAL BIO MED. 2007;42(4):460-465.

[Need and utilization of psychosocial care after liver transplantation]
Schulz K, Ewers H, Rogiers X, Koch-Gromus U
PSYCHOTHER PSYCH MED. 2007;57(5):221-230.

Carbon monoxide inhalation rescues mice from fulminant hepatitis through improving hepatic energy metabolism.
Tsui T, Obed A, Siu Y, Yet S, Prantl L, Schlitt H, Fan S
SHOCK. 2007;27(2):165-171.

Malignancies after renal transplantation during 33 years at a single center.
Végso G, Tóth M, Hídvégi M, Toronyi E, Langer R, Dinya E, Tóth A, Perner F, Járay J
PATHOL ONCOL RES. 2007;13(1):63-69.

Regeneration in pig livers by compensatory hyperplasia induces high levels of telomerase activity.
Wege H, Müller A, Müller L, Petri S, Petersen J, Hillert C
Comp Hepatol. 2007;6:6.

2006

Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis.
Almog N, Henke V, Flores L, Hlatky L, Kung A, Wright R, Berger R, Hutchinson L, Naumov G, Bender E, Akslen L, Achilles E, Folkman J
FASEB J. 2006;20(7):947-949.

Diaphragmatic hernia resulting in enterothorax following pediatric liver transplantation: a rare complication.
Englert C, Helmke K, Briem-Richter A, Beckmann M, Rogiers X, Burdelski M, Ganschow R
TRANSPLANTATION. 2006;82(4):574-576.

MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.
Foote C, Greer W, Kiberd B, Fraser A, Lawen J, Nashan B, Belitsky P
TRANSPL P. 2006;38(9):2847-2849.

Preoperative volume calculation of the hepatic venous draining areas with multi-detector row CT in adult living donor liver transplantation: Impact on surgical procedure.
Frericks B, Kirchhoff T, Shin H, Stamm G, Merkesdal S, Abe T, Schenk A, Peitgen H, Klempnauer J, Galanski M, Nashan B
EUR RADIOL. 2006;16(12):2803-2810.

Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
Ganschow R, Albani J, Grabhorn E, Briem-Richter A, Burdelski M
PEDIATR TRANSPLANT. 2006;10(2):220-224.

Hemangioblasts and their progeny.
Gehling U
METHOD ENZYMOL. 2006;419:179-193.

Neonatal hemochromatosis: long-term experience with favorable outcome.
Grabhorn E, Briem-Richter A, Burdelski M, Rogiers X, Ganschow R
PEDIATRICS. 2006;118(5):2060-2065.

Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.
Kirchner G, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, Strassburg C, Barg-Hock H, Wagner S, Lück R, Klempnauer J, Manns M
LIVER TRANSPLANT. 2006;12(8):1268-1277.

Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: decision making for orthotopic liver transplantation.
Koenecke C, Kleine M, Schrem H, Krug U, Nashan B, Neipp M, Ganser A, Hertenstein B, Klempnauer J
INT J HEMATOL. 2006;83(3):271-274.

Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.
Lerut J, Orlando G, Adam R, Sabbà C, Pfitzmann R, Klempnauer J, Belghiti J, Pirenne J, Thevenot T, Hillert C, Brown C, Gonze D, Karam V, Boillot O
ANN SURG. 2006;244(6):854-854.

Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
Levy G, Schmidli H, Punch J, Tuttle-Newhall E, Mayer D, Neuhaus P, Samuel D, Nashan B, Klempnauer J, Langnas A, Calmus Y, Rogiers X, Abecassis M, Freeman R, Sloof M, Roberts J, Fischer L
LIVER TRANSPLANT. 2006;12(11):1640-1648.

Acute liver failure induced by green tea extracts: case report and review of the literature.
Molinari M, Watt K, Kruszyna T, Nelson R, Walsh M, Huang W, Nashan B, Peltekian K
LIVER TRANSPLANT. 2006;12(12):1892-1895.

Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.
Nashan B, Suwelack B, Ivens K, Arns W, Lhotta K, Bourbigot B, Budde K, Fischer W, Pietruck F
TRANSPL P. 2006;38(9):2856-2859.

A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.
Rifai K, Kirchner G, Bahr M, Cantz T, Rosenau J, Nashan B, Klempnauer J, Manns M, Strassburg C
LIVER TRANSPLANT. 2006;12(3):411-415.

Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.
Rosenau J, Hooman N, Rifai K, Solga T, Tillmann H, Grzegowski E, Nashan B, Klempnauer J, Strassburg C, Wedemeyer H, Manns M
TRANSPL INT. 2006;19(10):828-833.

FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia.
Salvadori M, Budde K, Charpentier B, Klempnauer J, Nashan B, Pallardo L, Eris J, Schena F, Eisenberger U, Rostaing L, Hmissi A, Aradhye S
AM J TRANSPLANT. 2006;6(12):2912-2921.

Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids.
Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger A, Pollok J, Menard R, Heussler V
SCIENCE. 2006;313(5791):1287-1290.

Morphological and functional analysis of rat hepatocyte spheroids generated on poly(L-lactic acid) polymer in a pulsatile flow bioreactor.
Török E, Vogel C, Lütgehetmann M, Ma P, Dandri-Petersen M, Petersen J, Burda M, Siebert K, Düllmann J, Rogiers X, Pollok J
TISSUE ENG. 2006;12(7):1881-1890.

Adeno-associated virus-mediated heme oxygenase-1 gene transfer suppresses the progression of micronodular cirrhosis in rats.
Tsui T, Lau C, Ma J, Glockzin G, Obed A, Schlitt H, Fan S
WORLD J GASTROENTERO. 2006;12(13):2016-2023.

Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients.
Vincenti F, de Andrés A, Becker T, Choukroun G, Cole E, González-Posada J, Kumar M, Moore R, Nadalin S, Nashan B, Rostaing L, Saito K, Yoshimura N
TRANSPL INT. 2006;19(6):446-457.

Long-term outcome of split liver transplantation using right extended grafts in adulthood: A matched pair analysis.
Wilms C, Walter J, Kaptein M, Mueller L, Lenk C, Sterneck M, Hillert C, Fischer L, Rogiers X, Broering D
ANN SURG. 2006;244(6):863-865.

Cytoglobin overexpression protects against damage-induced fibrosis.
Xu R, Harrison P, Chen M, Li L, Tsui T, Fung P, Cheung P, Wang G, Li H, Diao Y, Krissansen G, Xu S, Farzaneh F
MOL THER. 2006;13(6):1093-1100.

Vascular wall resident progenitor cells: a source for postnatal vasculogenesis.
Zengin E, Chalajour F, Gehling U, Ito W, Treede H, Lauke H, Weil J, Reichenspurner H, Kilic N, Ergün S
DEVELOPMENT. 2006;133(8):1543-1551.

2005

Changes of duplex parameters and splenic size in liver transplant recipients during a long period of observation.
Boozari B, Gebel M, Bahr M, Manns M, Strassburg C, Bleck J, Klempnauer J, Nashan B
WORLD J GASTROENTERO. 2005;11(43):6787-6791.

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.
Dandri-Petersen M, Burda M, Zuckerman D, Wursthorn K, Matschl U, Pollok J, Rogiers X, Gocht A, Köck J, Blum H, von Weizsäcker F, Petersen J
J HEPATOL. 2005;42(1):54-60.

Chronic allograft nephropathy in athymic nude rats after adoptive transfer of primed T lymphocytes.
Doege C, Koch M, Heratizadeh A, Sótonyi P, Mengel M, Nashan B
TRANSPL INT. 2005;18(8):981-991.

Hypogammaglobulinemia in pediatric liver transplant recipients.
Ganschow R, Englert C, Grabhorn E, Briem-Richter A, Hinrichs B, Broering D, Rogiers X, Burdelski M
PEDIATR TRANSPLANT. 2005;9(2):215-219.

Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors.
Gehling U, Willems M, Dandri-Petersen M, Petersen J, Berna M, Thill M, Wulf T, Müller L, Pollok J, Schlagner K, Faltz C, Hossfeld D, Rogiers X
J HEPATOL. 2005;43(5):845-853.

Quality of life following living donor nephrectomy comparing classical flank incision and anterior vertical mini-incision.
Jackobs S, Becker T, Lück R, Jäger M, Nashan B, Gwinner W, Schwarz A, Klempnauer J, Neipp M
WORLD J UROL. 2005;23(5):343-348.

Adoptive transfer of primed CD4+ T-lymphocytes induces pattern of chronic allograft nephropathy in a nude rat model
Koch M, Joosten S, Mengel M, van Kooten C, Paul L, Nashan B
TRANSPLANTATION. 2005;79(7):753-761.

Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins.
Lau D, Mollnau H, Eiserich J, Freeman B, Daiber A, Gehling U, Brümmer J, Rudolph V, Münzel T, Heitzer T, Meinertz T, Baldus S
P NATL ACAD SCI USA. 2005;102(2):431-436.

Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
Loges S, Heil G, Bruweleit M, Schoder V, Butzal M, Fischer U, Gehling U, Schuch G, Hossfeld D, Fiedler W
J CLIN ONCOL. 2005;23(6):1109-1117.

Tumor growth-promoting cellular host response during liver atrophy after portal occlusion.
Mueller L, Göttsche J, Abdulgawad A, Vashist Yogesh K, Meyer J, Wilms C, Hillert C, Rogiers X, Broering Dieter C
LIVER INT. 2005;25(5):994-1001.

Use of Neoral C monitoring: a European consensus.
Nashan B, Bock A, Bosmans J, Klemens B, Fijter H, Jaques B, Johnston A, Lück R, Midtvedt K, Pallardó L, Ready A, Salamé E, Salizzoni M, Suarez F, Thervet E
TRANSPL INT. 2005;18(7):768-778.

Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review.
Nashan B
BIODRUGS. 2005;19(1):39-46.

Hepatoblastoma in a child with progressive familial intrahepatic cholestasis.
Richter A, Grabhorn E, Briem-Richter A, Schaefer H, Burdelski M, Ganschow R
PEDIATR TRANSPLANT. 2005;9(6):805-808.

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H, Mourad G, Kahan B, Boira J, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y
TRANSPLANTATION. 2005;79(11):1553-1560.

Heme oxygenase-1-derived carbon monoxide stimulates adenosine triphosphate generation in human hepatocyte.
Tsui T, Siu Y, Schlitt H, Fan S
BIOCHEM BIOPH RES CO. 2005;336(3):898-902.

rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats.
Tsui T, Lau C, Ma J, Wu X, Wang Y, Farkas S, Xu R, Schlitt H, Fan S
HEPATOLOGY. 2005;42(2):335-342.

The liver stage of Plasmodium berghei inhibits host cell apoptosis.
van de Sand C, Horstmann S, Schmidt A, Sturm A, Bolte S, Krueger A, Lütgehetmann M, Pollok J, Libert C, Heussler V
MOL MICROBIOL. 2005;58(3):731-742.

Costimulation blockade with belatacept in renal transplantation.
Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran P, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B
NEW ENGL J MED. 2005;353(8):770-781.

Bilirubin derived from heme degradation suppresses MHC class II expression in endothelial cells.
Wu J, Ma J, Fan S, Schlitt H, Tsui T
BIOCHEM BIOPH RES CO. 2005;338(2):890-896.

2004

Leprosy accidentally transmitted from a patient to a surgeon in a nonendemic area.
Achilles E, Hagel C, Vierbuchen M, Dietrich M
ANN INTERN MED. 2004;141(3):51.

Platelet P-selectin and GPIIb/IIIa expression after liver transplantation and resection.
Becker T, Jüttner B, Elsner H, Andreas M, Bornscheuer A, Nashan B, Brandl M, Klempnauer J, Piepenbrock S, Scheinichen D
TRANSPL INT. 2004;17(8):442-448.

Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis.
Beecken W, Engl T, Blaheta R, Bentas W, Achilles E, Jonas D, Shing Y, Camphausen K
ANGIOGENESIS. 2004;7(1):69-73.

The year in review--2004.
Belitsky P, Nashan B, Kiberd B, West K, Legare J, Keough-Ryan T, Watt K
CLIN TRANSPLANT. 2004;269-301.

[Present state of radio frequency ablation of liver tumors in Germany]
Birth M, Hildebrand P, Dahmen G, Ziegler A, Bröring D, Hillert C, Bruch H
CHIRURG. 2004;75(4):417-423.

Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases.
Broering D, Wilms C, Bok P, Fischer L, Mueller L, Hillert C, Lenk C, Kim J, Sterneck M, Schulz K, Krupski G, Nierhaus A, Ameis D, Burdelski M, Rogiers X
ANN SURG. 2004;240(6):1013-1016.

One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future.
Broering D, Kim J, Mueller T, Fischer L, Ganschow R, Bicak T, Mueller L, Hillert C, Wilms C, Hinrichs B, Helmke K, Pothmann W, Burdelski M, Rogiers X
ANN SURG. 2004;240(6):1002-1012.

Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.
Butzal M, Loges S, Schweizer M, Fischer U, Gehling U, Hossfeld D, Fiedler W
EXP CELL RES. 2004;300(1):65-71.

Laparoscopic fenestration of posttransplant lymphoceles in children.
Dammeier B, Lehnhardt A, Glüer S, Offner G, Nashan B, Ure B
J PEDIATR-US. 2004;39(8):1230-1232.

3D CT modeling of hepatic vessel architecture and volume calculation in living donated liver transplantation.
Frericks B, Caldarone F, Nashan B, Savellano D, Stamm G, Kirchhoff T, Shin H, Schenk A, Selle D, Spindler W, Klempnauer J, Peitgen H, Galanski M
EUR RADIOL. 2004;14(2):326-333.

Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications.
Hagenmeyer E, Häussler B, Hempel E, Grannas G, Kaló Z, Kilburg A, Nashan B
TRANSPLANTATION. 2004;77(10):1545-1550.

Serologic evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients.
Haubitz M, Votsch K, Woywodt A, Nashan B, Groh A, Haller H, Brunkhorst R
TRANSPLANTATION. 2004;77(10):1517-1521.

Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.
Johnston A, Belitsky P, Frei U, Horvath J, Hoyer P, Helderman J, Oellerich M, Pollard S, Riad H, Rigotti P, Keown P, Nashan B
EUR J CLIN PHARMACOL. 2004;60(6):389-395.

Identification of the adult human hemangioblast.
Loges S, Fehse B, Brockmann M, Lamszus K, Butzal M, Guckenbiehl M, Schuch G, Ergün S, Fischer U, Zander A, Hossfeld D, Fiedler W, Gehling U
STEM CELLS DEV. 2004;13(3):229-242.

Detection of Chlamydia pneumoniae in liver transplant patients with chronic allograft rejection.
Lotz G, Simon S, Patonai A, Sótonyi P, Nemes B, Sergi C, Glasz T, Füle T, Nashan B, Schaff Z
TRANSPLANTATION. 2004;77(10):1522-1528.

Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
Lück R, Böger J, Kuse E, Klempnauer J, Nashan B
LIVER TRANSPLANT. 2004;10(5):686-691.

Renal allograft allocation for children: are we penalizing children to not penalize adults?
Nashan B
TRANSPLANTATION. 2004;77(8):1145-1146.

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the myfortic prospective multicenter study.
Nashan B, Ivens K, Suwelack B, Arns W, Abbud Filho M
TRANSPL P. 2004;36(2):.

Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study.
Nashan B, Curtis J, Ponticelli C, Mourad G, Jaffe J, Haas T
TRANSPLANTATION. 2004;78(9):1332-1340.

Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors.
Nashan B
TRANSPL INT. 2004;17(6):279-285.

Living donor nephrectomy: flank incision versus anterior vertical mini-incision.
Neipp M, Jackobs S, Becker T, Vilsendorf Z, Meyer A, Winny M, Lueck R, Nashan B, Nashan B
TRANSPLANTATION. 2004;78(9):1356-1361.

Liver transplantation using organs from donors older than 60 years.
Neipp M, Bektas H, Lueck R, Ceylan D, Becker T, Klempnauer J, Nashan B
TRANSPL INT. 2004;17(8):416-423.

Stem cells: shibboleths of development.
Parker G, Anastassova-Kristeva M, Broxmeyer H, Dodge W, Eisenberg L, Gehling U, Guenin L, Huss R, Moldovan Nicanor I, Rao M, Srour E, Yoder M
STEM CELLS DEV. 2004;13(6):579-584.

Update on liver transplantation using cyclosporine.
Schrem H, Lück R, Becker T, Nashan B, Klempnauer J
TRANSPL P. 2004;36(9):2525-2531.

Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation.
Soares M, Seldon M, Gregoire I, Vassilevskaia T, Berberat P, Yu J, Tsui T, Bach F
J IMMUNOL. 2004;172(6):3553-3563.

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H, Mourad G, Kahan B, Boira J, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y
TRANSPLANTATION. 2004;77(12):1826-1833.

Long-term outcome of liver transplantation for autoimmune hepatitis.
Vogel A, Heinrich E, Bahr M, Rifai K, Flemming P, Melter M, Klempnauer J, Nashan B, Manns M, Strassburg C
CLIN TRANSPLANT. 2004;18(1):62-69.

Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
Wiegand J, Tischendorf J, Nashan B, Klempnauer J, Flemming P, Niemann P, Rohde P, Manns M, Trautwein C, Tillmann H
Z GASTROENTEROL. 2004;42(1):15-18.

Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts.
Yamashita K, McDaid J, Ollinger R, Tsui T, Berberat P, Usheva A, Csizmadia E, Smith R, Soares M, Bach F
FASEB J. 2004;18(6):765-767.

Heme oxygenase-1 potentiates the survival of small-for-size liver graft.
Yang Z, Tsui T, Ho D, Tang T, Fan S
LIVER TRANSPLANT. 2004;10(6):784-793.

2003

[Surgical treatment for hilar cholangiocarcinoma (Klatskin's tumor)]
Becker T, Lehner F, Bektas H, Meyer A, Lück R, Nashan B, Klempnauer J
ZBL CHIR. 2003;128(11):928-935.

Results of combined and sequential liver-kidney transplantation.
Demirci G, Becker T, Nyibata M, Lueck R, Bektas H, Lehner F, Tusch G, Strassburg C, Schwarz A, Klempnauer J, Nashan B
LIVER TRANSPLANT. 2003;9(10):1067-1078.

Ambulatory long-term pH monitoring in pigs.
Gawad K, Wachowiak R, Rempf C, Tiefenbacher W, Strate T, Achilles E, Blöchle C, Izbicki J
SURG ENDOSC. 2003;17(10):1556-1560.

Liver transplantation in patients with liver cirrhosis and esophageal bleeding.
Hillert C, Fischer L, Broering D, Rogiers X
LANGENBECK ARCH SURG. 2003;388(3):150-154.

[Functions of circulating and intra-abdominal polymorphonuclear leukocytes during human secondary peritonitis].
Holzer K, Briem-Richter A, Konietzny P, Schübel F, Wilhelm K, Henrich D
ZBL CHIR. 2003;128(4):291-297.

Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients.
Klemens B, Robert L, Nashan B, Brunkhorst R, Peter W, Mayer T, Brookman L, Nedelman J, Skerjanec A, Böhler T, Neumayer H
AM J TRANSPLANT. 2003;3(7):846-854.

[Living kidney transplantation. A comparison of Scandinavian countries and Germany]
Lück R, Schrem H, Neipp M, Nashan B, Klempnauer J
CHIRURG. 2003;74(6):523-529.

A retrospective study comparing the different surgical procedures for the treatment of hydatid disease of the liver.
Mueller L, Broering D, Vashist Y, Fischer L, Hillert C, Rogiers X
DIGEST SURG. 2003;20(4):279-284.

Sustained function in atrophying liver tissue after portal branch ligation in the rat.
Mueller L, Grotelueschen R, Meyer J, Vashist Y, Abdulgawad A, Wilms C, Hillert C, Rogiers X, Broering D
J SURG RES. 2003;114(2):146-155.

Review of T-cell activation: impact of Janus kinase 3 inhibition.
Nashan B
TRANSPLANTATION. 2003;75(11):1783-1785.

A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001.
Pollard S, Nashan B, Johnston A, Hoyer P, Belitsky P, Keown P, Helderman H
CLIN THER. 2003;25(6):1654-1669.

Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2alpha in end-stage liver disease.
Tsikas D, Iris R, Becker T, Nashan B, Klempnauer J, Frölich J
HEPATOLOGY. 2003;38(4):1063-1064.

Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer.
Tsui T, Wu X, Lau C, Ho D, Xu T, Siu Y, Fan S
CIRCULATION. 2003;107(20):2623-2629.

Long-term liver allograft survival induced by combined treatment with rAAV-hCTLA4Ig gene transfer and low-dose FK506.
Yang Z, Wu X, Tsui T, Hou Y, Luk J, Fan S
TRANSPLANTATION. 2003;75(3):303-308.

Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
Yang Z, Wu X, Tsui T, Hou Y, Luk J, Fan S
LIVER TRANSPLANT. 2003;9(4):411-420.

2002

Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.
Broering D, Hillert C, Krupski G, Fischer L, Mueller L, Achilles E, Jan S, Rogiers X
J GASTROINTEST SURG. 2002;6(6):905-913.

Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer.
Cheung S, Tsui T, Wang W, Yang Z, Wong S, Ip Y, Luk J, Fan S
J GASTROEN HEPATOL. 2002;17(9):1008-1014.

The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation.
Chilcott J, Holmes M, Walters S, Akehurst R, Nashan B
TRANSPL INT. 2002;15(9-10):486-493.

First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients.
Klemens B, Schmouder R, Brunkhorst R, Nashan B, Lücker P, Mayer T, Choudhury S, Skerjanec A, Kraus G, Neumayer H
J AM SOC NEPHROL. 2002;13(4):1073-1083.

Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation.
Koch M, Niemeyer G, Patel I, Light S, Nashan B
TRANSPLANTATION. 2002;73(10):1640-1646.

Hepatic reticuloendothelial function during parenteral nutrition including an MCT/LCT or LCT emulsion after liver transplantation - a double-blind study.
Kuse E, Kotzerke J, Müller S, Nashan B, Lück R, Jaeger K
TRANSPL INT. 2002;15(6):272-277.

Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression.
Lehner F, Becker T, Sybrecht L, Lück R, Schwinzer R, Slateva K, Blasczyk R, Hertenstein B, Klempnauer J, Nashan B
TRANSPLANTATION. 2002;73(2):307-310.

Review of the proliferation inhibitor everolimus.
Nashan B
EXPERT OPIN INV DRUG. 2002;11(12):1845-1857.

Early clinical experience with a novel rapamycin derivative.
Nashan B
THER DRUG MONIT. 2002;24(1):53-58.

Expansion of the donor pool in liver transplantation: the Hannover experience 1996-2002.
Nashan B, Lück R, Becker T, Grannas G, Strassburg C, Schneider A, Melter M, Strassburg A, Klempnauer J
CLIN TRANSPLANT. 2002;221-228.

Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations.
Neipp M, Offner G, Lück R, Latta K, Strehlau J, Schlitt H, Ehrich J, Klempnauer J, Nashan B
TRANSPLANTATION. 2002;73(3):409-416.

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.
Neuhaus P, Clavien P, Kittur D, Salizzoni M, Rimola A, Abeywickrama K, Ortmann E, Chodoff L, Hall M, Korn A, Nashan B
LIVER TRANSPLANT. 2002;8(2):132-142.

Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipients.
Niemeyer G, Koch M, Light S, Kuse E, Nashan B
AM J TRANSPLANT. 2002;2(5):454-460.

Single centre experience with basiliximab in paediatric renal transplantation.
Pape L, Strehlau J, Henne T, Latta K, Nashan B, Ehrich J, Klempnauer J, Offner G
NEPHROL DIAL TRANSPL. 2002;17(2):276-280.

Liver transplantation for liver cirrhosis in cystic fibrosis.
Pfister E, Strassburg A, Nashan B, Becker T, Ballmann M, Arning A, Ehrich J, Melter M
TRANSPL P. 2002;34(6):2281-2282.

Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
Rosenau J, Bahr M, von Wasielewski R, Mengel M, Schmidt H, Nashan B, Lang H, Klempnauer J, Manns M, Boeker K
TRANSPLANTATION. 2002;73(3):386-394.

Human antibody deposition, complement activation, and DNA fragmentation are observed for porcine hepatocytes in a clinically applied bioartificial liver assist system.
Schulte Arn Esch J, Hamann D, Soltau M, Zante B, Jungbluth M, Sputtek A, Nierhaus A, Hillert C, Broering D, Rogiers X
TRANSPL P. 2002;34(6):2321.

Basiliximab reduces acute liver allograft rejection in pediatric patients.
Strassburg A, Pfister E, Arning A, Nashan B, Ehrich J, Melter M
TRANSPL P. 2002;34(6):2374-2375.

Rapamycin blocks the generation of regulatory T cells facilitated by posttransplant infusion of donor T cells through increasing the apoptosis of thymic CD4(+)CD25(+) cells.
Tsui T, Lau C, Schlitt H, Fan S
TRANSPL P. 2002;34(5):1390-1391.

Delayed low-level calcineurin inhibition promotes allospecific tolerance induction by posttransplantation donor leukocyte infusion.
Tsui T, Jäger M, Deiwick A, Aselmann H, Neipp M, Fan S, Schlitt H
TRANSPLANTATION. 2002;73(8):1325-1332.

Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy.
Udagawa T, Fernandez A, Achilles E, Folkman J, D'Amato R
FASEB J. 2002;16(11):1361-1370.

2001

Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice.
Achilles E, Fernandez A, Allred E, Kisker O, Udagawa T, Beecken W, Flynn E, Folkman J
JNCI-J NATL CANCER I. 2001;93(14):1075-1081.

Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
Beecken W, Fernandez A, Joussen A, Achilles E, Flynn E, Lo K, Gillies S, Javaherian K, Folkman J, Shing Y
JNCI-J NATL CANCER I. 2001;93(5):382-387.

Is there still a need for living-related liver transplantation in children?
Broering D, Mueller L, Ganschow R, Kim J, Achilles E, Schäfer H, Gundlach M, Fischer L, Sterneck M, Hillert C, Helmke K, Izbicki J, Burdelski M, Rogiers X
ANN SURG. 2001;234(6):712-713.

Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.
Bumgardner G, Hardie I, Johnson R, Lin A, Nashan B, Pescovitz M, Ramos E, Vincenti F
TRANSPLANTATION. 2001;72(5):839-845.

Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation.
Dandri-Petersen M, Burda M, Gocht A, Török E, Pollok J, Rogler C, Will H, Petersen J
HEPATOLOGY. 2001;34(4 Pt 1):824-833.

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.
Dandri-Petersen M, Burda M, Török E, Pollok J, Iwanska A, Sommer G, Rogiers X, Rogler C, Gupta S, Will H, Greten H, Petersen J
HEPATOLOGY. 2001;33(4):981-988.

Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation.
Hillert C, Broering D, Gundlach M, Knoefel W, Izbicki J, Rogiers X
LIVER TRANSPLANT. 2001;7(3):266-268.

Oxygen radical generation by emigrated, intra-abdominal, and circulating PMNLs during human secondary peritonitis.
Holzer K, Briem-Richter A, Henrich D, Wilhelm K, Encke A
SHOCK. 2001;15(2):90-94.

Features of tolerance achieved by antigen and a single injection of an anti-CD45 monoclonal antibody in rats.
Jäger M, Tsui T, Aselmann H, Dahlke M, Deiwick A, Neipp M, Klempnauer J, Wonigeit K, Schlitt H
TRANSPL P. 2001;33(1-2):142.

MHC class II compatibility between donor bone marrow and secondary organ grafts is required for tolerance based on mixed chimerism.
Jäger M, Tsui T, Timrott K, Aselmann H, Deiwick A, Neipp M, Wonigeit K, Klempnauer J, Schlitt H
TRANSPL P. 2001;33(1-2):176.

Fast quantification method for sirolimus and its major metabolites.
Kirchner G, Jacobsen W, Deters M, Christians U, Nashan B, Winkler M, Vidal C, Kaever V, Sewing K, Manns M
TRANSPL P. 2001;33(1-2):1091-1092.

Generation of multiple angiogenesis inhibitors by human pancreatic cancer.
Kisker O, Onizuka S, Banyard J, Komiyama T, Becker C, Achilles E, Barnes C, O'Reilly M, Folkman J, Pirie-Shepherd S
CANCER RES. 2001;61(19):7298-7304.

Liver transplantation today.
Klempnauer J, Schrem H, Becker T, Nashan B, Lück R
TRANSPL P. 2001;33(7-8):3433-3435.

Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
Ko S, Jager M, Tsui T, Deiwick A, Dinkel A, Rohde F, Dahlke M, Lauth O, Wonigeit K, Schlitt H
TRANSPLANTATION. 2001;71(8):1124-1131.

Bone marrow aplasia induced by passenger leukocytes from heart allografts.
Ko S, Dahlke M, Lauth O, Jäger M, Deiwick A, Dinkel A, Tsui T, Wonigeit K, Schlitt H
EXP HEMATOL. 2001;29(3):339-344.

A population pharmacokinetic screen to identify demographic-clinical covariates of basiliximab in liver transplantation.
Kovarik J, Nashan B, Neuhaus P, Clavien P, Gerbeau C, Hall M, Korn A
CLIN PHARMACOL THER. 2001;69(4):201-209.

The IL2 pathway in clinical immunosuppression.
Nashan B
TRANSPL P. 2001;33(7-8):3072-3074.

The role of Certican (everolimus, rad) in the many pathways of chronic rejection.
Nashan B
TRANSPL P. 2001;33(7-8):3215-3220.

Islets of Langerhans encapsulated with a tissue-engineered membrane of rat chondrocytes maintain insulin secretion and glucose-insulin feedback for at least 30 days in culture.
Pollok J, Kölln P, Lorenzen M, Török E, Kaufmann P, Kluth D, Bohuslavizki K, Gundlach M, Rogiers X
TRANSPL P. 2001;33(1-2):1713-1714.

In vitro function of islets of Langerhans encapsulated with a membrane of porcine chondrocytes for immunoisolation.
Pollok J, Lorenzen M, Kölln P, Török E, Kaufmann P, Kluth D, Bohuslavizki K, Gundlach M, Rogiers X
DIGEST SURG. 2001;18(3):204-210.

Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.
Rosenau J, Tillmann H, Bahr M, Trautwein C, Boeker K, Nashan B, Klempnauer J, Manns M
TRANSPL P. 2001;33(7-8):3637-3638.

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.
Schlitt H, Barkmann A, Böker K, Schmidt H, Emmanouilidis N, Rosenau J, Bahr M, Tusch G, Manns M, Nashan B, Klempnauer J
LANCET. 2001;357(9256):587-591.

Clinical and subclinical acute rejection early after liver transplantation: contributing factors and relevance for the long-term course.
Tippner C, Nashan B, Hoshino K, Schmidt-Sandte E, Akimaru K, Böker K, Schlitt H
TRANSPLANTATION. 2001;72(6):1122-1128.

Optimization of hepatocyte spheroid formation for hepatic tissue engineering on three-dimensional biodegradable polymer within a flow bioreactor prior to implantation.
Török E, Pollok J, Ma P, Kaufmann P, Dandri-Petersen M, Petersen J, Burda M, Kluth D, Perner F, Rogiers X
CELLS TISSUES ORGANS. 2001;169(1):34-41.

Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor.
Török E, Pollok J, Ma P, Vogel C, Dandri-Petersen M, Petersen J, Burda M, Kaufmann P, Kluth D, Rogiers X
DIGEST SURG. 2001;18(3):196-203.

Induction of peripheral tolerance by posttransplant infusion of donor splenocytes.
Tsui T, Jäger M, Deiwick A, Klempnauer J, Schlitt H
TRANSPL P. 2001;33(1-2):187-188.

Hepatocyte transplantation using biodegradable matrices in ascorbic acid-deficient rats: comparison with heterotopically transplanted liver grafts.
Uyama S, Kaufmann P, Kneser U, Fiegel H, Pollok J, Kluth D, Vacanti J, Rogiers X
TRANSPLANTATION. 2001;71(9):1226-1231.

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.
Vincenti F, Ramos E, Brattstrom C, Cho S, Ekberg H, Grinyo J, Johnson R, Kuypers D, Stuart F, Khanna A, Navarro M, Nashan B
TRANSPLANTATION. 2001;71(9):1282-1287.

2000

Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil.
Barkmann A, Nashan B, Schmidt H, Böker K, Emmanouilidis N, Rosenau J, Bahr M, Hoffmann M, Manns M, Klempnauer J, Schlitt H
TRANSPLANTATION. 2000;69(9):1886-1890.

Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken W, Fernandez A, Panigrahy D, Achilles E, Kisker O, Flynn E, Joussen A, Folkman J, Shing Y
UROLOGY. 2000;56(3):521-526.

Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis.
Ekberg H, Bäckman L, Tufveson G, Tydén G, Nashan B, Vincenti F
TRANSPL INT. 2000;13(2):151-159.

Endothelial-like cells derived from human CD14 positive monocytes.
Fernandez Pujol B, Lucibello F, Gehling U, Lindemann K, Weidner N, Zuzarte M, Adamkiewicz J, Elsässer H, Müller R, Havemann K
DIFFERENTIATION. 2000;65(5):287-300.

[Curative therapy of hepatocellular carcinoma (HCC). Resection or transplantation?]
Hillert C, Rogiers X
INTERNIST. 2000;41(2 Pt 2):191-197.

Native pyeloureterostomy after kidney transplantation: experience in 48 cases.
Schult M, Küster J, Kliem V, Brunkhorst R, Nashan B, Oldhafer K, Schlitt H
TRANSPL INT. 2000;13(5):340-343.

Interleukin-2 receptor antibody-induced alterations of ciclosporin dose requirements in paediatric transplant recipients.
Strehlau J, Pape L, Offner G, Nashan B, Ehrich J
LANCET. 2000;356(9238):1327-1328.

Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group.
Thistlethwaite J, Nashan B, Hall M, Chodoff L, Lin T
TRANSPLANTATION. 2000;70(5):784-790.

Specific immunosuppression by postoperative infusion of allogeneic spleen cells: requirement of donor major histocompatibility complex expression and graft-versus-host reactivity.
Tsui T, Deiwick A, Ko S, Schlitt H
TRANSPLANTATION. 2000;69(1):25-30.

1999

In vitro demonstration of survival and secretory function of islets of Langerhans encapsulated with a membrane of tissue-engineered chondrocytes for immunoisolation.
Begemann J, Pollok J, Kaufmann P, Kluth D, Broelsch C, Rogiers X
TRANSPL P. 1999;31(8):3250-3252.

Expression patterns of integrin receptors and extracellular matrix proteins in chronic rejection of human liver allografts.
Demirci G, Hoshino K, Nashan B
TRANSPL IMMUNOL. 1999;7(4):229-237.

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma.
Graeven U, Andre N, Achilles E, Zornig C, Schmiegel W
J CANCER RES CLIN. 1999;125(10):577-581.

Is there an optimal concentration of cotransplanted islets of Langerhans for stimulation of hepatocytes in three dimensional matrices?
Kaufmann P, Kneser U, Fiegel H, Pollok J, Kluth D, Izbicki J, Herbst H, Rogiers X
TRANSPLANTATION. 1999;68(2):272-279.

Influence of pancreatic islets on growth and differentiation of hepatocytes in co-culture.
Kaufmann P, Fiegel H, Kneser U, Pollok J, Kluth D, Rogiers X
TISSUE ENG. 1999;5(6):583-596.

Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients.
Kliem V, Boeck A, Eisenberger U, Petersen R, Radermacher J, Hiss M, Pethig M, Koch K, Nashan B, Brunkhorst R
TRANSPL P. 1999;31(1-2):1312-1313.

Heterotopic hepatocyte transplantation utilizing pancreatic islet cotransplantation for hepatotrophic stimulation: morphologic and morphometric evaluation.
Kneser U, Kaufmann P, Fiegel H, Pollok J, Kluth D, Herbst H, Rogiers X
PEDIATR SURG INT. 1999;15(3-4):168-174.

Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices.
Kneser U, Kaufmann P, Fiegel H, Pollok J, Kluth D, Herbst H, Rogiers X
J Biomed Mater Res. 1999;47(4):494-503.

Interaction of hepatocytes and pancreatic islets cotransplanted in polymeric matrices.
Kneser U, Kaufmann P, Fiegel H, Pollok J, Rogiers X, Kluth D, Herbst H
VIRCHOWS ARCH. 1999;435(2):125-132.

The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat.
Ko S, Deiwick A, Jäger M, Dinkel A, Rohde F, Fischer R, Tsui T, Rittmann K, Wonigeit K, Schlitt H
NAT MED. 1999;5(11):1292-1297.

Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H, Schlitt H, Schmidt H, Flemming P, Nashan B, Scheumann G, Oldhafer K, Manns M, Raab R
LANGENBECK ARCH SURG. 1999;384(4):370-377.

Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor.
Marx G, Nashan B, Cobas Meyer M, Vangerow B, Schlitt H, Ziesing S, Leuwer M, Piepenbrock S, Rueckoldt H
INTENS CARE MED. 1999;25(9):1017-1020.

CMV in kidney transplantation: a single center experience over 22 years.
Nashan B, Lück R, Kliem V, Brunkhorst R, Schlitt H, Klempnauer J
CLIN TRANSPLANT. 1999;181-188.

The interleukin-2 inhibitors and their role in low-toxicity regimens.
Nashan B
TRANSPL P. 1999;31(8):.

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.
Nashan B, Light S, Hardie I, Lin A, Johnson J
TRANSPLANTATION. 1999;67(1):110-115.

Long-term insulin-secretory function of islets of Langerhans encapsulated with a layer of confluent chondrocytes for immunoisolation.
Pollok J, Begemann J, Kaufmann P, Kluth D, Broelsch C, Izbicki J, Rogiers X
PEDIATR SURG INT. 1999;15(3-4):164-167.

Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.
Schlitt H, Neipp M, Weimann A, Oldhafer K, Schmoll E, Boeker K, Nashan B, Kubicka S, Maschek H, Tusch G, Raab R, Ringe B, Manns M, Pichlmayr R
J CLIN ONCOL. 1999;17(1):324-331.

Peripheral hepatojejunostomy as palliative treatment for irresectable malignant tumors of the liver hilum.
Schlitt H, Weimann A, Klempnauer J, Oldhafer K, Nashan B, Raab R, Pichlmayr R
ANN SURG. 1999;229(2):181-186.

Attitudes of patients before and after transplantation towards various allografts.
Schlitt H, Brunkhorst R, Schmidt H, Nashan B, Haverich A, Raab R
TRANSPLANTATION. 1999;68(4):510-514.

Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation.
Schlitt H, Meier P, Nashan B, Oldhafer K, Boeker K, Flemming P, Raab R, Manns M, Pichlmayr R
ANN SURG. 1999;229(1):137-145.

Familial Amyloidotic Polyneuropathy: domino liver transplantation.
Schmidt H, Nashan B, Pröpsting M, Nakazato M, Flemming P, Kubicka S, Böker K, Pichlmayr R, Manns M
J HEPATOL. 1999;30(2):293-298.

Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy.
Schult M, Löhmann D, Knitsch W, Kuse E, Nashan B
TRANSPLANTATION. 1999;67(11):1497-1498.

Can antibody prophylaxis allow sparing of other immunosuppressives?
Vincenti F, Grinyo J, Ramos E, Nashan B, Stuart F, Kuypers D, Brattstrom C, Cho S, Ekberg H, Johnson R
TRANSPL P. 1999;31(1-2):1246-1248.

Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma.
Widjaja A, Wagner S, Mix H, Rifai K, Rambusch E, Stolte M, Meier P, Nashan B, Reimann J, Böker K, Heil G, Manns M
Z GASTROENTEROL. 1999;37(7):611-614.

1998

Laparoscopic vs open repair of gastric perforation and abdominal lavage of associated peritonitis in pigs.
Bloechle C, Emmermann A, Strate T, Scheurlen U, Schneider C, Achilles E, Wolf M, Mack D, Zornig C, Broelsch C
SURG ENDOSC. 1998;12(3):212-218.

[Is resection of colorectal liver metastases still justified in very elderly patients?]
Brunken C, Rogiers X, Malagó M, Hillert C, Zornig C, Busch C, Izbicki J, Broelsch C
CHIRURG. 1998;69(12):1334-1339.

Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
Hengst K, Nashan B, Avenhaus W, Ullerich H, Schlitt H, Flemming P, Pichlmayr R, Domschke W
Z GASTROENTEROL. 1998;36(3):239-245.

Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: a panel histochemical study.
Kiuchi T, Oldhafer K, Schlitt H, Nashan B, Deiwick A, Wonigeit K, Ringe B, Tanaka K, Yamaoka Y, Pichlmayr R
TRANSPLANTATION. 1998;66(6):737-747.

Disposition and immunodynamics of basiliximab in liver allograft recipients.
Kovarik J, Breidenbach T, Gerbeau C, Korn A, Schmidt A, Nashan B
CLIN PHARMACOL THER. 1998;64(1):66-72.

Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?
Oldhafer K, Chavan A, Frühauf N, Flemming P, Schlitt H, Kubicka S, Nashan B, Weimann A, Raab R, Manns M, Galanski M
J HEPATOL. 1998;29(6):953-959.

[Immuno-isolation of xenogenic islands of Langerhans in a tissue engineered autologous cartilage capsule]
Pollok J, Ibarra C, Broelsch C, Vacanti J
ZBL CHIR. 1998;123(7):830-833.

Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions.
Pollok J, Kluth D, Cusick R, Lee H, Utsunomiya H, Ma P, Langer R, Broelsch C, Vacanti J
EUR J PEDIATR SURG. 1998;8(4):195-199.

[De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates]
Rambusch E, Nashan B, Tillmann H, Böker K, Schlitt H, Maschek H, Raab R, Manns M
Z GASTROENTEROL. 1998;36(12):1027-1035.

Ovarian-like stroma in an invasive mucinous cystadenocarcinoma of the pancreas positive for inhibin. A hint concerning its possible histogenesis.
Ridder G, Maschek H, Flemming P, Nashan B, Klempnauer J
VIRCHOWS ARCH. 1998;432(5):451-454.

Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.
Tillmann H, Heringlake S, Trautwein C, Meissner D, Nashan B, Schlitt H, Kratochvil J, Hunt J, Qiu X, Lou S, Pichlmayr R, Manns M
HEPATOLOGY. 1998;28(2):379-384.

Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups.
Vincenti F, Nashan B, Light S
TRANSPL P. 1998;30(5):2155-2158.

[The current diagnosis of primary sclerosing cholangitis]
Wagner S, Maschek H, Meier P, Nashan B, Manns M
DEUT MED WOCHENSCHR. 1998;123(10):291-295.

[State-of-the-art therapy for primary sclerosing cholangitis]
Wanger S, Meier P, Maschek H, Nashan B, Manns M
DEUT MED WOCHENSCHR. 1998;123(11):325-327.

Outcome of 22 successful pregnancies after liver transplantation.
Wu A, Nashan B, Messner U, Schmidt H, Guenther H, Niesert S, Pichmayr R
CLIN TRANSPLANT. 1998;12(5):454-464.

1997

The effect of donor and recipient age on engraftment of tissue-engineered liver.
Cusick R, Lee H, Sano K, Pollok J, Utsunomiya H, Ma P, Langer R, Vacanti J
J PEDIATR SURG. 1997;32(2):357-360.

Release of daunorubicin from polymethylmethacrylate for the improvement of the local growth control of bone metastasis animal experiments.
Fröschle G, Mählitz J, Langendorff H, Achilles E, Pollock J, Jungbluth K
ANTICANCER RES. 1997;17(2):995-1002.

Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients.
Haubitz M, Kliem V, Koch K, Nashan B, Schlitt H, Pichlmayr R, Brunkhorst R
TRANSPLANTATION. 1997;63(9):1251-1257.

Early acute rejection after hepatic graft reperfusion: association with ischemic injury with good function, oxygenation heterogeneity, and leukocyte adhesion without aggregation.
Kiuchi T, Schlitt H, Oldhafer K, Nashan B, Tanaka A, Wonigeit K, Ringe B, Tanaka K, Yamaoka Y, Pichlmayr R
TRANSPL P. 1997;29(1-2):364-365.

Outcome of kidney transplantation in patients with systemic autoimmune diseases.
Kliem V, Haubitz M, Ehlerding G, Nashan B, Schlitt H, Oldhafer K, Pichlmayr R, Koch K, Brunkhorst R
TRANSPL P. 1997;29(1-2):957-958.

Liver transplantation in patients with polycystic liver disease.
Lang H, von Woellwarth J, Oldhafer K, Behrend M, Schlitt H, Nashan B, Pichlmayr R
TRANSPL P. 1997;29(7):2832-2833.

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
Nashan B, Moore R, Amlot P, Schmidt A, Abeywickrama K, Soulillou J
LANCET. 1997;350(9086):1193-1198.

[Complicated amebic liver abscess--course and therapy]
Nierhaus A, Pothmann W, Pollok J, Schäfer P, Mack D
ANASTH INTENSIV NOTF. 1997;32(8):518-521.

Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss.
Ohmacht C, Kliem V, Burg M, Nashan B, Schlitt H, Brunkhorst R, Koch K, Floege J
TRANSPLANTATION. 1997;64(10):1493-1496.

A new method of xenotransplantation using autologous cartilage as an immunoisolation barrier for the transplantation of xenogeneic islets of Langerhans.
Pollok J, Ibarra C, Vacanti J
TRANSPL P. 1997;29(1-2):909-911.

Immunoisolation of xenogeneic islets using a living tissue engineered cartilage barrier.
Pollok J, Ibarra C, Vacanti J
TRANSPL P. 1997;29(4):2131-2133.

1996

Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3.
Demirci G, Nashan B, Pichlmayr R
TRANSPLANTATION. 1996;62(12):1776-1783.

Chronic rejection in lung allografts: immunohistological analysis of fibrogenesis.
Hirabayashi T, Demertzis S, Schäfers J, Hoshino K, Nashan B
TRANSPL INT. 1996;9(1):293-295.

Histochemical analysis of tissue injury in human hepatic grafts: potential usefulness in graft assessment before implantation.
Kiuchi T, Oldhafer K, Schlitt H, Nashan B, Deiwick A, Wonigeit K, Yamaoka Y, Pichlmayr R
TRANSPL P. 1996;28(1):70-72.

Toxic megacolon caused by cytomegalovirus colitis in a multiply injured patient.
Machens A, Bloechle C, Achilles E, Bause H, Izbicki J
J TRAUMA. 1996;40(4):644-646.

Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients.
Nashan B, Schlitt H, Schwinzer R, Ringe B, Kuse E, Tusch G, Wonigeit K, Pichlmayr R
TRANSPLANTATION. 1996;61(4):546-554.

[Liver transplantation in patients with primary sclerosing cholangitis.Determining timing with reference to risk of malignancy]
Nashan B, Tusch G, Schlitt H, Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:410-412.

Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.
Nashan B, Schlitt H, Tusch G, Oldhafer K, Ringe B, Wagner S, Pichlmayr R
HEPATOLOGY. 1996;23(5):1105-1111.

Tissue engineering.
Pollok J, Vacanti J
SEMIN PEDIATR SURG. 1996;5(3):191-196.

Regenerative signals for heterotopic hepatocyte transplantation.
Sano K, Cusick R, Lee H, Pollok J, Kaufmann P, Uyama S, Mooney D, Langer R, Vacanti J
TRANSPL P. 1996;28(3):1857-1858.

Endoscopic management of biliary tract strictures in primary sclerosing cholangitis.
Wagner S, Gebel M, Meier P, Trautwein C, Bleck J, Nashan B, Manns M
ENDOSCOPY. 1996;28(7):546-551.

1995

Effect of a pneumoperitoneum on the extent and severity of peritonitis induced by gastric ulcer perforation in the rat.
Bloechle C, Emmermann A, Treu H, Achilles E, Mack D, Zornig C, Broelsch C
SURG ENDOSC. 1995;9(8):898-901.

Evidence for transformation of lipocytes to myofibroblast-like cells as source of transplant fibrosis in chronic human allograft rejection.
Hoshino K, Demirci G, Schlitt H, Wonigeit K, Pichlmayr R, Nashan B
TRANSPL P. 1995;27(1):1144-1145.

Long-term chimerism in liver transplantation: no evidence for immunological relevance but requirement for graft persistence.
Hundrieser J, Hisanaga M, Böker K, Raddatz G, Brederlau A, Nashan B, Pichlmayr R, Schlitt H
TRANSPL P. 1995;27(1):216-218.

Backgrounds of early intragraft immune activation and rejection in liver transplant recipients. Impact of graft reperfusion quality.
Kiuchi T, Schlitt H, Oldhafer K, Nashan B, Ringe B, Kitai T, Tanaka A, Wonigeit K, Yamaoka Y, Pichlmayr R
TRANSPLANTATION. 1995;60(1):49-55.

Early intragraft inflammatory events of liver allografts leading to chronic rejection.
Lautenschlager I, Nashan B, Schlitt H, Ringe B, Wonigeit K, Pichlmayr R
TRANSPL INT. 1995;8(6):446-451.

Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients.
Nashan B, Schwinzer R, Schlitt H, Wonigeit K, Pichlmayr R
TRANSPL IMMUNOL. 1995;3(3):203-211.

Evidence for migration of lipocytes (ITO cells) in human liver allografts with chronic dysfunction or rejection.
Nashan B, Hoshino K, Deiwick A, Demirci G, Böker K, Pichlmayr R, Schlitt H
TRANSPL P. 1995;27(1):219-220.

Extramedullary erythropoiesis in human liver grafts.
Schlitt H, Schäfers S, Deiwick A, Eckardt K, Pietsch T, Ebell W, Nashan B, Ringe B, Wonigeit K, Pichlmayr R
HEPATOLOGY. 1995;21(3):689-696.

1994

[Positive cytokeratin results in malignant melanoma. Pitfall in differential immunohistologic diagnosis of occult neoplasms]
Achilles E, Schröder S
PATHOLOGE. 1994;15(4):235-241.

Review: recent developments in adrenal surgery.
Dralle H, Scheumann G, Nashan B, Brabant G
ACTA CHIR BELG. 1994;94(3):137-140.

Expression of cell-matrix molecules and integrin receptors in human liver grafts during chronic rejection.
Hoshino K, Nashan B, Steinhoff G, Pichlmayr R
TRANSPL INT. 1994;7(1):637-640.

Steroid-resistant rejection after renal transplantation.
Hoyer P, Offner G, Brodehl J, Nashan B, Wonigeit K, Pichlmayr R
TRANSPL P. 1994;26(1):67-68.

Spontaneous proliferation of peripheral blood lymphocytes as an indicator of intragraft immune activation in liver transplant patients.
Kiuchi T, Kato H, Kanaya S, Nashan B, Schlitt H, Inamoto T, Ringe B, Ozawa K, Pichlmayr R
CLIN TRANSPLANT. 1994;8(4):382-387.

Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
Lautenschlager I, Nashan B, Schlitt H, Hoshino K, Ringe B, Tillmann H, Manns M, Wonigeit K, Pichlmayr R
TRANSPLANTATION. 1994;58(12):1339-1345.

Liver transplantation as an option in patients with cholangiocellular and bile duct carcinoma.
Ringe B, Weimann A, Lamesch P, Nashan B, Pichlmayr R
Cancer Treat Res. 1994;69:259-275.

Isolation of CD34-positive hematopoietic progenitor cells.
Shpall E, Gehling U, Cagnoni P, Purdy M, Hami L, Gee A
Immunomethods. 1994;5(3):197-203.

1993

Detection of donor lymphocytes in human hepatic grafts with immune activation but no clinical rejection.
Kanehiro H, Steinhoff G, Nashan B, Pichlmayr R, Schlitt H
TRANSPL P. 1993;25(2):1764-1765.

Routine monitoring of liver grafts by transplant aspiration cytology: clinical experience with 3000 TACs.
Schlitt H, Nashan B, Ringe B, Wonigeit K, Pichlmayr R
TRANSPL P. 1993;25(2):1970-1971.

Persistence of donor lymphocytes in liver allograft recipients.
Schlitt H, Kanehiro H, Raddatz G, Steinhoff G, Richter N, Nashan B, Ringe B, Wonigeit K, Pichlmayr R
TRANSPLANTATION. 1993;56(4):1001-1007.

1992

Intragraft immune events after human liver transplantation. Correlation with clinical signs of acute rejection and influence of immunosuppression.
Schlitt H, Nashan B, Krick P, Ringe B, Wittekind C, Wonigeit K, Pichlmayr R
TRANSPLANTATION. 1992;54(2):273-278.

Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms.
Schröder S, Padberg B, Achilles E, Holl K, Dralle H, Klöppel G
Virchows Arch A Pathol Anat Histopathol. 1992;420(1):65-70.

1991

Immunocytochemistry of paragangliomas--value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis.
Achilles E, Padberg B, Holl K, Klöppel G, Schröder S
HISTOPATHOLOGY. 1991;18(5):453-458.

Differential diagnosis of viral infections and acute rejection episodes in liver grafted patients by transplant aspiration cytology.
Nashan B, Schlitt H, Ringe B, Bunzendahl H, Wittekind C, Wonigeit K, Pichlmayr R
TRANSPL P. 1991;23(1 Pt 2):1507-1508.

DNA cytophotometry in adrenocortical tumours: a clinicomorphological study of 66 cases.
Padberg B, Lauritzen I, Achilles E, Holl K, Bressel M, Klöppel G, Dralle H, Schröder S
Virchows Arch A Pathol Anat Histopathol. 1991;419(3):167-170.

Coagulation disorder during liver transplantation.
Sato M, Nashan B, Ringe B, Grosse H, Barthels M, Pichlmayr R
BLOOD COAGUL FIBRIN. 1991;2(1):25-31.

Hemostatic studies of ex situ hepatic surgery.
Sato M, Nashan B, Grosse H, Barthels M, Pichlmayr R
Jpn J Surg. 1991;21(5):561-565.

Differentiation of liver graft dysfunction by transplant aspiration cytology.
Schlitt H, Nashan B, Ringe B, Bunzendahl H, Wittekind C, Wonigeit K, Pichlmayr R
TRANSPLANTATION. 1991;51(4):786-793.

1990

Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsule.
Bleck J, Nashan B, Christians U, Schottmann R, Wonigeit K, Sewing K
ARZNEIMITTEL-FORSCH. 1990;40(1):62-64.

Transplantation aspiration cytology in the diagnosis of steroid resistant rejection in liver allograft patients.
Nashan B, Schlitt H, Ringe B, Bunzendahl H, Wonigeit K, Pichlmayr R
TRANSPL P. 1990;22(5):2297-2298.

[Histology, immunocytochemistry and DNA cytophotometry of adrenal glandpheochromocytoma (PCC)--a morphologic clinal study of 64 tumors]
Padberg B, Achilles E, Garbe E, Dralle H, Klöppel G, Schröder S
Verh Dtsch Ges Pathol. 1990;74:289-294.

Adrenomedullary hyperplasia and phaeochromocytoma. DNA cytophotometric findings in 47 cases.
Padberg B, Garbe E, Achilles E, Dralle H, Bressel M, Schröder S
Virchows Arch A Pathol Anat Histopathol. 1990;416(5):443-446.

Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11.
Schröder S, Niendorf A, Achilles E, Dietel M, Padberg B, Beisiegel U, Dralle H, Bressel M, Klöppel G
Virchows Arch A Pathol Anat Histopathol. 1990;417(2):89-96.

[Histology, immunocytochemistry and DNA cytophotometry of adrenocortical tumors--a clinicomorphological study of 72 tumors]
Schröder S, Padberg B, Achilles E, Lauritzen I, Dralle H, Klöppel G
Verh Dtsch Ges Pathol. 1990;74:284-288.

1989

Patterns of immune activation during the first four weeks in liver transplant patients.
Nashan B, Schlitt H, Wittekind C, Ringe B, Wonigeit K, Pichlmayr R
TRANSPL P. 1989;21(4):3623-3624.

Reactivity of patient antisera to OKT3 with a panel of CD3 monoclonal antibodies.
Nashan B, Schwinzer R, Wonigeit K, Pichlmayr R
TRANSPL P. 1989;21(1 Pt 1):985-986.

DNA cytophotometric findings in pheochromocytoma.
Padberg B, Garbe E, Achilles E, Dralle H, Bressel M, Schroder S
Henry Ford Hosp Med J. 1989;37(3-4):185-186.

Clinical usefulness of a semiquantitative scoring system for liver transplant aspiration cytology.
Schlitt H, Nashan B, Ringe B, Wittekind C, Wonigeit K, Pichlmayr R
TRANSPL P. 1989;21(4):3621-3622.

Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation.
Wonigeit K, Nashan B, Schwinzer R, Schlitt H, Kurrle R, Racenberg J, Seiler F, Ringe B, Pichlmayr R
TRANSPL P. 1989;21(1 Pt 2):2258-2259.

1988

Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.
Nashan B, Bleck J, Wonigeit K, Vogt P, Christians U, Sewing K, Beveridge T, Pichlmayr R
TRANSPL P. 1988;20(2 Suppl 2):637-639.

High incidence of monoclonal immunoglobulins in patients after liver or heart transplantation.
Peest D, Schaper B, Nashan B, Wonigeit K, Raude E, Pichlmayr R, Haverich A, Deicher H
TRANSPLANTATION. 1988;46(3):389-393.

Increased frequency of CD8+CD11+ cells expressing the T cell receptor in long-term allograft recipients.
Wonigeit K, Schwinzer R, Nashan B, Vogt P, Pichlmayr R
TRANSPL P. 1988;20(2 Suppl 2):173-178.

1987

Fine specificity of a panel of antibodies against the TCR/CD3 complex.
Nashan B, Wonigeit K, Schwinzer R, Schlitt H, Kurrle R, Pichlmayr R
TRANSPL P. 1987;19(5):4270-4272.

Selective increase of CD8+ CD11+ cells in long-term liver allograft recipients.
Schwinzer R, Wonigeit K, Nashan B, Pichlmayr R
TRANSPL P. 1987;19(5):3812-3814.

1985

[D-Met2,Pro5]enkephalinamide activates cardioinhibitory efferents in anaesthetized dogs.
Inoue K, Nashan B, Arndt J
EUR J PHARMACOL. 1985;110(2):233-239.

1984

Droperidol inhibits cardiac vagal efferents in dogs.
Nashan B, Inoue K, Arndt J
BRIT J ANAESTH. 1984;56(11):1259-1266.

Letzte Aktualisierung aus dem FIS: 23.06.2017 - 00:11 Uhr